<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Vet Sci</journal-id><journal-id journal-id-type="iso-abbrev">Vet Sci</journal-id><journal-id journal-id-type="publisher-id">vetsci</journal-id><journal-title-group><journal-title>Veterinary Sciences</journal-title></journal-title-group><issn pub-type="epub">2306-7381</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40005882</article-id><article-id pub-id-type="pmc">PMC11861797</article-id><article-id pub-id-type="doi">10.3390/vetsci12020122</article-id><article-id pub-id-type="publisher-id">vetsci-12-00122</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Individual Genomic Loci, Transcript Level and Serum Profile of Immune, Antioxidant and Hormonal Markers Associated with Sheep Arthritis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Darwish</surname><given-names>Asmaa</given-names></name><xref rid="af1-vetsci-12-00122" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Ateya</surname><given-names>Ahmed</given-names></name><xref rid="af2-vetsci-12-00122" ref-type="aff">2</xref><xref rid="c1-vetsci-12-00122" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-6613-1498</contrib-id><name><surname>Alghamdi</surname><given-names>Mansour A.</given-names></name><xref rid="af3-vetsci-12-00122" ref-type="aff">3</xref><xref rid="af4-vetsci-12-00122" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name><surname>El-Sayed</surname><given-names>Ahmed</given-names></name><xref rid="af1-vetsci-12-00122" ref-type="aff">1</xref><xref rid="c1-vetsci-12-00122" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Carrasco Otero</surname><given-names>Librado</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-vetsci-12-00122"><label>1</label>Department of Animal Health and Poultry, Animal and Poultry Production Division, Desert Research Center (DRC), Cairo 11753, Egypt; <email>asmaa_vet25@drc.gov.eg</email></aff><aff id="af2-vetsci-12-00122"><label>2</label>Department of Development of Animal Wealth, Faculty of Veterinary Medicine, Mansoura University, Mansoura 35516, Egypt</aff><aff id="af3-vetsci-12-00122"><label>3</label>Department of Anatomy, College of Medicine, King Khalid University, Abha 62529, Saudi Arabia; <email>m.alghamdi@kku.edu.sa</email></aff><aff id="af4-vetsci-12-00122"><label>4</label>Genomics and Personalized Medicine Unit, The Center for Medical and Health Research, King Khalid University, Abha 62529, Saudi Arabia</aff><author-notes><corresp id="c1-vetsci-12-00122"><label>*</label>Correspondence: <email>dr_ahmedismail@mans.edu.eg</email> (A.A.); <email>decernes@drc.gov.eg</email> (A.E.-S.); Tel.: +20-10-0354-1921 (A.A.); +20-1112242510 (A.E.-S.); Fax: +20-502372592 (A.A.); +20-20678275 (A.E.-S.)</corresp></author-notes><pub-date pub-type="epub"><day>03</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2025</year></pub-date><volume>12</volume><issue>2</issue><elocation-id>122</elocation-id><history><date date-type="received"><day>30</day><month>12</month><year>2024</year></date><date date-type="rev-recd"><day>27</day><month>1</month><year>2025</year></date><date date-type="accepted"><day>31</day><month>1</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract abstract-type="plain-language-summary"><title>Simple Summary</title><p>Arthritis is an inflammatory condition that impacts joints&#x02019; constituent parts. Immunological and antioxidant indicators have a major role in the generation and regulation of the inflammatory response. In this study, 30 rams with arthritis and 30 rams in good condition were employed for biochemical and gene expression research. The results of this study revealed that there were gene expression, nucleotide sequence and biochemical variations between the healthy and arthritis rams. The shift in the profile of the examined markers points to a potential source of sheep arthritis indications.</p></abstract><abstract><title>Abstract</title><p>Arthritis is a leading cause of economic loss in livestock farming including sheep. This study examined the changes in gene expression, antioxidants, pro-inflammatory cytokines, acute-phase proteins (APPs), hormonal assays and iron profiles linked to sheep arthritis, as well as the diagnostic utility of these markers. Blood samples were obtained from 30 apparently healthy rams and 30 rams with arthritis for gene expression and biochemical analyses. Gene expression intensities were much higher in the arthritis-affected rams than in the healthy ones for the genes <italic toggle="yes">IL-1&#x003b1;</italic>, <italic toggle="yes">IL-1&#x003b2;</italic>, <italic toggle="yes">IL-6</italic>, <italic toggle="yes">IL-10</italic>, <italic toggle="yes">TNF&#x003b1;</italic>, <italic toggle="yes">NCF4</italic>, <italic toggle="yes">NFKB</italic>, <italic toggle="yes">TMED</italic>, <italic toggle="yes">FCAMR</italic>, <italic toggle="yes">iNOS</italic> and <italic toggle="yes">COX18</italic>. The <italic toggle="yes">SOD3</italic>, <italic toggle="yes">CAT</italic>, <italic toggle="yes">GPX</italic> and <italic toggle="yes">ATOX1</italic> genes were expressed at substantially lower levels in arthritis-affected rams. Disparities in the nucleotide sequence variants for the amplified DNA bases linked to arthritis for the studied genes were found in the PCR-DNA sequence verdicts of the affected and healthy rams. Immunological, acute-phase protein (APP), antioxidant, hormonal and iron profiles were estimated in both groups and statistically analyzed. The arthritic group in relation to the healthy one showed a significant (<italic toggle="yes">p</italic> &#x0003c; 0.05) increase in pro-inflammatory cytokines, APPs, free radicals, immunoglobulins, cortisol, GH, TSH, ferritin, TIBC and UIBC and a significant (<italic toggle="yes">p</italic> &#x002c2; 0.05) decrease in anti-inflammatory cytokines, antioxidants, complements, insulin, T3, T4, SI, and Tf and Tf sat.% serum levels. The estimated pro-inflammatory cytokines and APPs achieved high values of sensitivity and specificity, positive predictive values (PPVs), negative predictive values (NPVs), a high accuracy rate and a moderate likelihood ratio (LR). The study concluded that ovine arthritis stimulates innate and humeral immunity, resulting in prominent alterations in gene expression, pro-inflammatory cytokines, APP assays and antioxidant profiles, which could be valuable indicators of sheep arthritis.</p></abstract><kwd-group><kwd>sheep arthritis</kwd><kwd>immune response</kwd><kwd>gene expression</kwd><kwd>antioxidants</kwd><kwd>hormones</kwd><kwd>iron</kwd></kwd-group><funding-group><award-group><funding-source>Deanship of Research and Graduate Studies at King Khalid University</funding-source><award-id>RGP2/312/45</award-id></award-group><funding-statement>The authors extend their appreciation to the Deanship of Research and Graduate Studies at King Khalid University for funding this work through the Large Research Project under grant number RGP2/312/45.</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-vetsci-12-00122"><title>1. Introduction</title><p>According to [<xref rid="B1-vetsci-12-00122" ref-type="bibr">1</xref>], arthritis is an inflammatory disorder that affects the components of the joints. It can cause a variety of symptoms, including loss of appetite, fever, difficulty standing, increased synovial fluid, joint capsule strains, the weakening of muscles, pain, swelling and lameness. Weight loss, poor reproductive outcomes, lower-quality carcasses, medical expenses and early herd separation owing to disease are all financial losses that result from it [<xref rid="B2-vetsci-12-00122" ref-type="bibr">2</xref>]. Bacterial arthritis predominates in ruminants, including sheep [<xref rid="B3-vetsci-12-00122" ref-type="bibr">3</xref>]. The most frequent bacterial species found in sheeps&#x02019; afflicted joints are <italic toggle="yes">Erysipelothrix rhusiopathiae</italic>, <italic toggle="yes">Histophilus ovis</italic>, <italic toggle="yes">Escherichia coli</italic> and a few species of <italic toggle="yes">Streptococci</italic> and <italic toggle="yes">Staphylococci</italic> [<xref rid="B4-vetsci-12-00122" ref-type="bibr">4</xref>]. Although they are less common, viral diseases such as FMD and blue tongue may also be a factor in sheep arthritis [<xref rid="B4-vetsci-12-00122" ref-type="bibr">4</xref>]. In small ruminants, bacterial infections are more common in the distal joints and can result from contamination, hematogenous seeding, neighboring illness or direct trauma [<xref rid="B5-vetsci-12-00122" ref-type="bibr">5</xref>]. Sheep arthritis is predisposed by joint injury, ear marking, castration, mulesing, shearing, grazing and dipping [<xref rid="B6-vetsci-12-00122" ref-type="bibr">6</xref>]. Inadequate management of arthritis in ruminants can lead to significant discomfort that lasts for a long time, reduced joint function, a limited range of motion and even the eventual degeneration of joint, bone and cartilage.</p><p>To properly manage the illness and return the joint to a normal physiology, early diagnosis and timely, efficient therapy are crucial. According to [<xref rid="B4-vetsci-12-00122" ref-type="bibr">4</xref>], it is common practice to use diagnostic imaging, clinical signs and tests of blood and synovial fluid to confirm a diagnosis. A key step in enhancing the precision and effectiveness of care and treatment regimens for sheep with arthritis is learning more about how the immune system responds to the condition and how it changes immune and antioxidant profiles, which will eventually aid in the recovery of the physiology of the afflicted joints [<xref rid="B4-vetsci-12-00122" ref-type="bibr">4</xref>].</p><p>The production and control of the immune inflammatory response are largely mediated by cytokines [<xref rid="B7-vetsci-12-00122" ref-type="bibr">7</xref>]. Cytokines have a crucial role in regulating the kind, strength and persistence of immune responses by influencing cell development, maturation, activation, proliferation and differentiation [<xref rid="B8-vetsci-12-00122" ref-type="bibr">8</xref>].</p><p>The majority of the acute-phase proteins (APP) in an infected animal&#x02019;s blood come from the liver, help to maintain homeostasis, prevent pathological damage and stop the growth of microorganisms without the use of antibodies [<xref rid="B9-vetsci-12-00122" ref-type="bibr">9</xref>]. APP concentrations respond to infection, inflammation and internal or external challenges by either increasing (positive) or decreasing (negative) in plasma. This information is useful for prognostication and diagnosis during infection and inflammation, with notable species-specific variations [<xref rid="B10-vetsci-12-00122" ref-type="bibr">10</xref>].</p><p>When antioxidant resources are depleted and oxidants such as free radicals and reactive oxygen species are abundant, oxidative stress can occur [<xref rid="B11-vetsci-12-00122" ref-type="bibr">11</xref>]. However, in order to control the excessive creation of free radicals, the animal body possesses antioxidant defense systems [<xref rid="B12-vetsci-12-00122" ref-type="bibr">12</xref>]. As such, antioxidant enzymes (i.e., catalases) play an important role in these defense mechanisms [<xref rid="B13-vetsci-12-00122" ref-type="bibr">13</xref>].</p><p>Advanced molecular genetic approaches may improve animal health and serve as an auxiliary to disease control [<xref rid="B14-vetsci-12-00122" ref-type="bibr">14</xref>]. Livestock disease susceptibility and resistance can be accurately predicted by a large number of genetic markers, most of which are single-nucleotide polymorphisms (SNPs) [<xref rid="B15-vetsci-12-00122" ref-type="bibr">15</xref>]. This suggests that there is variation in the degree of disease susceptibility or resistance among host genotypes [<xref rid="B16-vetsci-12-00122" ref-type="bibr">16</xref>]. Research on the immune system, antioxidant changes, SNPs, gene expression and sheep arthritis is still in its early stages. Therefore, the purpose of this study was to examine the relationship between sheep arthritis and SNPs, gene expression, the serum profile of immunological and antioxidant marker alterations and other risk factors.</p></sec><sec id="sec2-vetsci-12-00122"><title>2. Materials and Methods</title><sec id="sec2dot1-vetsci-12-00122"><title>2.1. Animals and Study Design</title><p>In this study, 60 adult Barki rams from various cities in the Matrouh province of Egypt were used. They ranged in body weight from 50 to 60 kg (mean &#x000b1; SD: 53.6 &#x000b1; 3.9) and had an average age of three to four years (mean &#x000b1; SD: 3.5 &#x000b1; 0.3). The examined rams were 30 clinically healthy rams and 30 rams that suffered from arthritis. The criteria for inclusion in control group (CG) were having a normal body temperature, pulse, respiration rate, normal appetite, normal movement and intact joints, with no nasal or ocular discharge. Meanwhile, the criteria for the arthritic group (AC) were presence of clinical signs such as lameness in one or more legs (some were unable to stand), swollen joints, carrying the affected leg, high body temperature (40.8 &#x000b0;C), discomfort, pain and poor appetite. A thorough clinical evaluation was conducted on the rams under study, which included taking vital signs such as their heart rate, temperature and respiration rate [<xref rid="B17-vetsci-12-00122" ref-type="bibr">17</xref>]. Every day, the rams would eat 750 g of concentrate feed mixture (CFM) and 750 g of alfalfa hay in their semi-open, shaded quarters, with water available at all times. The CFM consisted of 300 kg of wheat bran, 250 kg of soy beans, 400 kg of corn, 10 kg of sodium chloride, 20 kg of calcium carbonate, 1 kg of premix, 0.5 kg of Netro-Nill and 0.5 kg of Fylax. In addition to ad libitim water, the rams were given two meals each day: breakfast and dinner. In accordance with the Egyptian Authority Program, the animals were given frequent vaccinations and dewormed.</p></sec><sec id="sec2dot2-vetsci-12-00122"><title>2.2. Blood Sampling and Measurements</title><p>The animals in both groups had ten milliliters of blood drawn from their jugular veins, which was then divided into three equal portions. Part one was mixed with EDTA and 5000 I.U. heparin calcium to prevent the blood from clotting. Part two was centrifuged at 3000 r.p.m. for 20 min at 37 &#x000b0;C to obtain serum, and part three was used for DNA and RNA extraction with the EDTA blood. For further biochemical evaluation in the control group (CG) and arthritic group (AG), plasma and serum samples were preserved at &#x02212;80 degrees Celsius in sterile Eppendorf tubes.</p></sec><sec id="sec2dot3-vetsci-12-00122"><title>2.3. Total RNA Extraction, Reverse Transcription and Quantitative Real-Time PCR</title><p>Trizol reagent (RNeasy Mini Ki, Catalogue no. 74104, Tustin, CA, USA) was used to isolate total RNA from ram blood in compliance with the manufacturer&#x02019;s recommendations. The amount of extracted RNA was quantified and qualified using the NanoDrop<sup>&#x000ae;</sup> ND-1000 spectrophotometer (UV-Vis spectrophotometer Q5000, Quawell Tech nology, San Jose, CA, USA). Following the manufacturing method (Thermo Fisher, Catalog no. EP0441, London, UK), cDNA was produced for each sample. The gene expression pattern for coding fragments of genes encoding defense (<italic toggle="yes">IL-1&#x003b1;</italic>, <italic toggle="yes">IL-1&#x003b2;</italic>, <italic toggle="yes">IL-6</italic>, <italic toggle="yes">IL-10</italic>, <italic toggle="yes">TNF&#x003b1;</italic>, <italic toggle="yes">NCF4</italic>, <italic toggle="yes">NFKB</italic>, <italic toggle="yes">TMED</italic>, <italic toggle="yes">FCAMR</italic> and <italic toggle="yes">iNOS</italic>) and antioxidants (<italic toggle="yes">SOD3</italic>, <italic toggle="yes">CAT</italic>, <italic toggle="yes">GPX</italic>, <italic toggle="yes">ATOX1</italic> and <italic toggle="yes">COX18</italic>) was assessed using quantitative RT-PCR with SYBR Green PCR Master Mix (2&#x000d7; SensiFastTM SYBR, Bioline, CAT No: Bio-98002, London, UK). The relative mRNA level was determined using real-time PCR using the SYBR Green PCR Master Mix (compatible with Quantitat SYBR Green PCR kit, Catalogue no. 204141).</p><p>Primers were designed using the <italic toggle="yes">Ovis aries</italic> sequence that was published in PubMed, as shown in <xref rid="vetsci-12-00122-t001" ref-type="table">Table 1</xref>. The housekeeping gene <italic toggle="yes">&#x000df;. actin</italic> was used as a constitutive control for normalization. The reaction mixture, which included total RNA, was prepared using a volume of 25 &#x000b5;L. This PCR master mix contains 12.5 &#x000b5;L of 2&#x000d7; Quantitect SYBR green, 0.5 &#x000b5;L of each primer, 0.25 &#x000b5;L of reverse transcriptase, 3 &#x000b5;L and 4 &#x000b5;L of 5&#x000d7; Trans Amp buffer and 8.25 &#x000b5;L of RNase-free water.</p><p>According to <xref rid="vetsci-12-00122-t001" ref-type="table">Table 1</xref>, reverse transcription was carried out for 30 min at 50 &#x000b0;C, followed by 10 min of primary denaturation at 94 &#x000b0;C, 40 cycles of 15 s at 94 &#x000b0;C, 1 min of annealing temperatures and, finally, 30 s at 72 &#x000b0;C. The last step was to place the reaction mixture in a thermal cycler. At the end of the amplification step, a melting curve analysis was performed to confirm the specificity of the PCR product. Using the 2<sup>&#x02212;&#x00394;&#x00394;Ct</sup> technique, we determined the relative expression of each gene in comparison to the &#x000df;. actin gene for each sample [<xref rid="B18-vetsci-12-00122" ref-type="bibr">18</xref>].</p></sec><sec id="sec2dot4-vetsci-12-00122"><title>2.4. DNA Sequencing and Polymorphism Detection</title><p>The DNA sequencing process began with the removal of primer dimers, nonspecific bands and any other potential contaminants. According to [<xref rid="B19-vetsci-12-00122" ref-type="bibr">19</xref>], the purification of real-time PCR products with the expected size (target bands) (Jena Bioscience # pp-201&#x000d7;s/Munich, Ham burg, Germany) was achieved using a PCR purification kit, following the manufacturer&#x02019;s instructions. In order to ensure that the PCR products were both sufficiently numerous and of high purity and to obtain high yields, a Nanodrop Uv-Vis spectrophotometer (Q5000/Waltham, MA, USA) was employed for protein measurement [<xref rid="B20-vetsci-12-00122" ref-type="bibr">20</xref>]. According to the enzymatic chain terminator technique created by [<xref rid="B21-vetsci-12-00122" ref-type="bibr">21</xref>], an ABI 3730XL DNA sequencer (Applied Biosystem, Waltham, MA, USA) was used to discover single-nucleotide polymorphisms (SNPs) in the genes studied in both control and arthritis-affected rams. PCR products bearing the target band were sent for forward and reverse DNA sequencing.</p><p>To analyze the DNA sequencing results, the programs Chromas 1.45 and Blast 2.0 were utilized [<xref rid="B22-vetsci-12-00122" ref-type="bibr">22</xref>]. Variations between the PCR findings of the genes under examination and the reference sequences found in GenBank were categorized as single-nucleotide polymorphisms (SNPs). The amino acid sequence variation of the investigated genes between the rams was determined using the MEGA6 software tool, which is based on data alignment of DNA sequencing [<xref rid="B23-vetsci-12-00122" ref-type="bibr">23</xref>].</p></sec><sec id="sec2dot5-vetsci-12-00122"><title>2.5. Biochemical Analysis</title><p>Through the use of MyBiosecure ELISA kits, the serum concentrations of pro-inflammatory cytokines (IL-1&#x003b1;, IL-1&#x003b2;, IL-6 and TNF-&#x003b1;) and anti-inflammatory cytokines (IL-10) are recorded. Fibrinogen (Fb), serum amyloid A (SAA) and haptoglobin (Hp) concentrations were determined (IBL International Crop ELISA kits (canda)<sup>&#x000ae;</sup> (M&#x000e4;nnedorf, Switzerland)). Caeruloplasmin (Cp) concentrations were determined in serum using a turbidimetric technique with kits from Elabscience USA<sup>&#x000ae;</sup> (Houston, TX, USA). Serum concentrations of free radicals (nitric oxide and malondialdehyde) and antioxidants (catalase, glutathione peroxidase and glutathione reductase) were measured spectrophotometrically using commercial kits from Biodiagnostic<sup>&#x000ae;</sup> (Worcester, UK). Serum immunoglobulin concentrations (IgG, IgM and IgA) were measured turbidimetrically with kits provided by Biorex Diagnostics<sup>&#x000ae;</sup> (Antrim, UK). Spectrophotometric analysis of serum iron (SI) and total iron binding capacity (TIBC) was performed using commercial kits from Biodiagnostic Company<sup>&#x000ae;</sup> (Worcester, UK). Levels of complement-3 (C3) and complement-4 (C4) in serum were measured by the enzyme-linked immunosorbent assay (ELISA) method using New Test Company<sup>&#x000ae;</sup> commercial kits (Hangzhou, China). Chemiluminescence immunoassay (CLIA) kits supplied by Diasorin<sup>&#x000ae;</sup> (Saluggia, Italy) were used for serum hormonal tests, which included measurements of growth hormone (GH), insulin, cortisol, TSH, T3 and T4. Transcriptional factor (Tf) concentrations in serum were determined with turbidimetric technique using Elabscience USA<sup>&#x000ae;</sup> assays. Iron concentrations in serum were determined using the chemiluminescence immunoassay (CLIA) technique with Abnova<sup>&#x000ae;</sup> (Taipei, Taiwan) diagnostic kits.<disp-formula>Transferrin saturation percentage (Tf sat %) = SI (Serum iron)/TIBC (Total iron capacity) &#x000d7; 100</disp-formula><disp-formula>Unsaturated iron binding capacity (UIBC) = SI &#x02212; TIBC</disp-formula></p></sec><sec id="sec2dot6-vetsci-12-00122"><title>2.6. Statistical Analysis</title><p>The rams that were being studied had their SNP distribution for the indicated genes analyzed using Fisher&#x02019;s exact test, which yielded a significant result (<italic toggle="yes">p</italic> &#x0003c; 0.01). The mean &#x000b1; standard deviation (SD) was used to represent the statistical parameters. We used SPSS program version 23 to statistically analyze the data. We used an independent-sample T-test to compare the means of the groups that were tested. We utilized Pearson&#x02019;s simple correlation method to find the relationships between the genetic, immunological, APP and antioxidant characteristics. At a significance level of <italic toggle="yes">p</italic> &#x0003c; 0.05, a difference was deemed to exist.</p><list list-type="simple"><list-item><label>&#x02212;</label><p>GraphPad Prism version 5 was used to estimate the cut-off points, sensitivity, specificity and likelihood ratio (LR) for the measured cytokines and APPs between the two groups.</p></list-item><list-item><label>&#x02212;</label><p>The following equations were used to compute the positive predictive value (PPV), negative predictive value (NPV), accuracy rate (AR) and percentages of increase for these variables:</p></list-item></list><disp-formula id="FD1-vetsci-12-00122">
<mml:math id="mm1" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="normal">V</mml:mi><mml:mo>=</mml:mo><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">u</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">p</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">v</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mo>&#x000f7;</mml:mo><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">p</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">v</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mo>&#x000d7;</mml:mo><mml:mn>100</mml:mn><mml:mo>.</mml:mo></mml:mrow></mml:mrow></mml:math>
</disp-formula><disp-formula id="FD2-vetsci-12-00122">
<mml:math id="mm2" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">N</mml:mi><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="normal">V</mml:mi><mml:mo>=</mml:mo><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">u</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">g</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">v</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mo>&#x000f7;</mml:mo><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">g</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">v</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mo>&#x000d7;</mml:mo><mml:mn>100</mml:mn><mml:mo>.</mml:mo></mml:mrow></mml:mrow></mml:math>
</disp-formula><disp-formula id="FD3-vetsci-12-00122">
<mml:math id="mm3" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">A</mml:mi><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">u</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">y</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mo>=</mml:mo><mml:mfenced separators="|"><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">u</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">p</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">v</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mo>+</mml:mo><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">u</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">g</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">v</mml:mi><mml:mi mathvariant="normal">e</mml:mi></mml:mrow></mml:mfenced><mml:mo>&#x000f7;</mml:mo><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">p</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">p</mml:mi><mml:mi mathvariant="normal">u</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mo>&#x000d7;</mml:mo><mml:mn>100</mml:mn><mml:mo>.</mml:mo></mml:mrow></mml:mrow></mml:math>
</disp-formula><disp-formula id="FD4-vetsci-12-00122">
<mml:math id="mm4" display="block" overflow="scroll"><mml:mrow><mml:mtable><mml:mtr columnalign="left"><mml:mtd><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">g</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">f</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">e</mml:mi></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="normal">h</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">v</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">u</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">f</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">h</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">k</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">A</mml:mi><mml:mi mathvariant="normal">G</mml:mi></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02212;</mml:mo><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="normal">h</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">v</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">u</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">f</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">C</mml:mi><mml:mi mathvariant="normal">G</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>&#x02009;</mml:mo><mml:mo>&#x000f7;</mml:mo><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="normal">h</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">v</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">u</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">f</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">C</mml:mi><mml:mi mathvariant="normal">G</mml:mi><mml:mo>&#x000d7;</mml:mo><mml:mn>100</mml:mn><mml:mo>.</mml:mo></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math>
</disp-formula></sec></sec><sec sec-type="results" id="sec3-vetsci-12-00122"><title>3. Results</title><sec id="sec3dot1-vetsci-12-00122"><title>3.1. Clinical Examination</title><p>The clinically healthy rams showed a normal body temperature, pulse, respiration rate, lack of nasal or ocular discharge, normal appetite, normal mobility and intact joints. Alternatively, the rams with arthritis showed signs of lameness in one or more legs (some were not even able to stand up), had swollen joints, carried the affected leg, and had an elevated body temperature (40.8 &#x000b0;C), pain, discomfort and a lack of appetite.</p></sec><sec id="sec3dot2-vetsci-12-00122"><title>3.2. Patterns for Transcript Levels of Immune and Antioxidant Indicators</title><p><xref rid="vetsci-12-00122-f001" ref-type="fig">Figure 1</xref> and <xref rid="vetsci-12-00122-f002" ref-type="fig">Figure 2</xref> showed the transcript profiles for the evaluated antioxidant and immunological indicators. The rams with arthritis showed significantly greater levels of gene expression for the genes <italic toggle="yes">IL-1&#x003b1;</italic>, <italic toggle="yes">IL-1&#x003b2;</italic>, <italic toggle="yes">IL-6</italic>, <italic toggle="yes">IL-10</italic>, <italic toggle="yes">TNF&#x003b1;</italic>, <italic toggle="yes">NCF4</italic>, <italic toggle="yes">NFKB</italic>, <italic toggle="yes">TMED</italic>, <italic toggle="yes">FCAMR</italic>, <italic toggle="yes">iNOS</italic> and <italic toggle="yes">COX18</italic> than did the healthy rams. The expression of the <italic toggle="yes">SOD3</italic>, <italic toggle="yes">CAT</italic>, <italic toggle="yes">GPX</italic> and <italic toggle="yes">ATOX1</italic> genes was significantly reduced in the rams with arthritis.</p><p>The highest possible level of mRNA for the arthritic rams was 2.18 &#x000b1; 0.18 for <italic toggle="yes">IL-1&#x003b1;</italic>, while the lowest amount of each gene was 0.37 &#x000b1; 0.09 for <italic toggle="yes">ATOX1</italic>. TMED had the lowest possible level of mRNA (0.33 &#x000b1; 0.08), while <italic toggle="yes">SOD3</italic> had the highest (2.29 &#x000b1; 0.08) among all the genes examined in the healthy rams.</p></sec><sec id="sec3dot3-vetsci-12-00122"><title>3.3. Genetic Polymorphisms of Immune and Antioxidant Genes</title><p><italic toggle="yes">IL-1&#x003b1;</italic> (466 bp), <italic toggle="yes">IL-1&#x003b2;</italic> (361 bp), <italic toggle="yes">IL-6</italic> (370 bp), <italic toggle="yes">IL-10</italic> (387 bp), <italic toggle="yes">TNF&#x003b1;</italic> (386 bp), <italic toggle="yes">NCF4</italic> (345 bp), <italic toggle="yes">NFKB</italic> (411 bp), <italic toggle="yes">TMED</italic> (408 bp), <italic toggle="yes">FCAMR</italic> (378 bp), <italic toggle="yes">iNOS</italic> (480 bp), <italic toggle="yes">SOD</italic> (381 bp), <italic toggle="yes">CAT</italic> (473 bp), <italic toggle="yes">GPX</italic> (416 bp), <italic toggle="yes">ATOX1</italic> (430 bp) and <italic toggle="yes">COX18</italic> (415 bp) PCR-DNA sequence judgments of healthy and affected rams showed variations in the amplified DNA bases linked to arthritis. Using the reference gene sequences from GenBank and the DNA sequence variations between the immunological and antioxidant indicators examined in the studied rams, all of the identified SNPs were accepted (<xref rid="app1-vetsci-12-00122" ref-type="app">Figures S1&#x02013;S15</xref>).</p><p>The single base difference distribution for immunological and antioxidant indicators differed significantly (<italic toggle="yes">p</italic> &#x0003c; 0.01) between the healthy and arthritis-affected rams, according to Fisher&#x02019;s exact analysis. <xref rid="vetsci-12-00122-t002" ref-type="table">Table 2</xref> showed that all of the immunological and antioxidant markers that were investigated had exonic region changes when comparing the coding DNA sequences of the affected and healthy rams. Eleven of the thirty-one SNPs found in the immunological and antioxidant genes were synonymous, whereas the other twenty-one were non-synonymous.</p><p>For the immune indicators of the <italic toggle="yes">IL-1&#x003b1;</italic> gene (466 bp), DNA sequencing was applied to discover three recurring SNPs; two of them, C185T and T191C, led to non-synonymous mutations: P62L and M64T, respectively. By contrast, the 121T amino acid was noted to be a result of the synonymous mutation A363C. The <italic toggle="yes">IL-1&#x003b2;</italic> gene (361 bp) enclosed four SNPs. Three SNPs were non-synonymous: C29T, C46A and T89C, which produced the amino acids S10L, A16T and L30P for exchange. Meanwhile, the synonymous SNP A58C was linked to amino acid 20R. Upon analyzing the 370 bp sequence of the <italic toggle="yes">IL-6</italic> gene, a recurrent SNP was discovered, C341T SNP, which resulted in the non-synonymous mutation T114I. When the 386 bp DNA sequence of the <italic toggle="yes">TNF&#x003b1;</italic> gene was analyzed, one recurrent SNP was discovered: C242T, which carried the non-synonymous mutation T81M. Two repetitive SNPs were found when the <italic toggle="yes">IL-10</italic> (387 bp) gene was sequenced. T39C involved the synonymous mutation 13R, and G219C involved the non-synonymous mutation that changed the amino acid R37S.</p><p>Two frequently occurring synonymous SNPs, C66T and A264G, were found in the 411 bp DNA structure of the <italic toggle="yes">NFKB</italic> marker and were linked to amino acids 22A and 88K, respectively. Five regular SNPs in the <italic toggle="yes">NCF4</italic> gene (345 bp) were found by DNA sequencing; four of these, G36T, C243T, G261A and A267G, resulted in synonymous changes of 12P, 81F, 87V and 89T, respectively. However, the non-synonymous mutation brought about by C38A SNP resulted in the production of amino acid R13K. The <italic toggle="yes">TMED1</italic> gene (408 bp) contains three repeating SNPs that were identified by DNA sequencing; two of them, G125C and T337C, produced non-synonymous mutations, G42A and W133L, respectively. On the other hand, amino acid 49V was produced by the synonymous mutation caused by SNP G147A. One recurrent SNP was identified during the 378 bp sequencing of the FCAMR gene, in which the synonymous mutation 90L was induced by the C268T SNP. When the 480 bp DNA sequence of the <italic toggle="yes">iNOS</italic> gene was analyzed, three recurrent SNPs were discovered: C38T, C77T and T410C, which carried the non-synonymous mutations S13L, S26L and M137T.</p><p>In terms of antioxidant markers, recurring non-synonymous SNPs were identified in the nucleotide categorization of <italic toggle="yes">SOD</italic> (381 bp), <italic toggle="yes">CAT</italic> (473 bp), <italic toggle="yes">ATOX1</italic> (430 bp) and <italic toggle="yes">COX18</italic> (415 bp) genes: S49R, T52M, R128P and V37A, respectively. These altered amino acids were caused by the C147G, C155T, G383C and T110C SNPs, respectively. Two repetitive SNPs were found when the <italic toggle="yes">GPX</italic> (416 bp) gene was sequenced. G193A and C298T involved the non-synonymous mutations H65N and R100C.</p></sec><sec id="sec3dot4-vetsci-12-00122"><title>3.4. Biochemical Profile</title><p>This study proved that sheep arthritis triggered a robust immune response, as shown by the significantly higher levels of pro-inflammatory cytokines (IL-1&#x003b1;, IL-1&#x003b2;, IL-6 and TNF-&#x003b1;), acute-phase proteins (Fb, Hp, SAA and Cp) and free radicals (NO and MDA) and the significantly lower levels of anti-inflammatory cytokines (IL-10), antioxidants (CAT, GR and GPx) and complements (C3 and C4) in AG compared to CG. Furthermore, blood cortisol, GH, TSH, ferritin, TIBC and UIBC levels were significantly higher (<italic toggle="yes">p</italic> &#x0003c; 0.05) in the AG compared to the CG, but serum insulin, T3, T4, SI, Tf and Tf sat. % levels were significantly lower (<italic toggle="yes">p</italic> &#x002c2; 0.05) (<xref rid="vetsci-12-00122-t003" ref-type="table">Table 3</xref>).</p><p>The estimated cytokines and APPs in the arthritic sheep had a high sensitivity, specificity, PPV and accuracy rate at AUC = 1, as well as moderate LRs (5&#x02013;10). Among them, Hp had the highest percentage of increase, suggesting that it is important for both diagnosis and prognosis (<xref rid="vetsci-12-00122-t004" ref-type="table">Table 4</xref>).</p></sec><sec id="sec3dot5-vetsci-12-00122"><title>3.5. Correlation Between Gene Expression Patterns and Serum Profiles of Immunological, APP and Antioxidant Markers</title><p>The mRNA levels of <italic toggle="yes">IL1-&#x003b1;</italic> were positively correlated with the serum level of MDA, TNF&#x003b1; and NO (r = 0.997, <italic toggle="yes">p</italic> = 0.04; r = 1, <italic toggle="yes">p</italic> = 0.001; and r = 0.998, <italic toggle="yes">p</italic> = 0.03), respectively. There was a positive correlation between the mRNA levels of IL1-&#x003b2; and the serum levels of CAT, IL6, IL1-&#x003b2;, Hp, Cp, Fb and GPx (r = 1, <italic toggle="yes">p</italic> = 0.002) and between MDA and NO (r = 1, <italic toggle="yes">p</italic> = 0.009, r = 0.999, <italic toggle="yes">p</italic> = 0.02), respectively. A positive correlation (r = 0.998, <italic toggle="yes">p</italic> = 0.04) was seen between the iNOS mRNA levels and the blood GSH level.</p></sec></sec><sec sec-type="discussion" id="sec4-vetsci-12-00122"><title>4. Discussion</title><p>The purpose of this study was to confirm that single-nucleotide polymorphisms (SNPs), changes in immunological and antioxidant markers, APP gene expression and serum profiles, and other similar variables can be used to diagnose arthritis in Barki rams. The prevalence of lameness in ruminants is a significant factor in the declining profitability of livestock husbandry. It is the second most common cause of animal slaughter after mastitis and low fertility [<xref rid="B24-vetsci-12-00122" ref-type="bibr">24</xref>]. Other indirect costs of lameness include decreased milk production, milk fat, protein and treatment expenses [<xref rid="B25-vetsci-12-00122" ref-type="bibr">25</xref>]. The arthritic rams had lameness in one or more legs, fever, emaciation, swollen joints, discomfort, pain and decreased appetite, according to a clinical examination. The aforementioned clinical indicators have been additionally detailed by [<xref rid="B1-vetsci-12-00122" ref-type="bibr">1</xref>,<xref rid="B26-vetsci-12-00122" ref-type="bibr">26</xref>] in sheep and [<xref rid="B6-vetsci-12-00122" ref-type="bibr">6</xref>] in calves.</p><p>We were able to compare the immune and antioxidant states of healthy rams to those of arthritic rams by analyzing the mRNA levels of antioxidant (<italic toggle="yes">SOD3</italic>, <italic toggle="yes">CAT</italic>, <italic toggle="yes">GPX</italic>, <italic toggle="yes">ATOX1</italic> and <italic toggle="yes">COX18</italic>) and immunological (<italic toggle="yes">IL-1&#x003b1;</italic>, <italic toggle="yes">IL-1&#x003b2;</italic>, <italic toggle="yes">IL-6</italic>, <italic toggle="yes">IL-10</italic>, <italic toggle="yes">TNF&#x003b1;</italic>, <italic toggle="yes">NCF4</italic>, <italic toggle="yes">NFKB</italic>, <italic toggle="yes">TMED</italic>, <italic toggle="yes">FCAMR</italic> and <italic toggle="yes">iNOS</italic>) genes. When comparing healthy rams to those with arthritis, the expression levels of the following genes were noticeably higher: <italic toggle="yes">IL-1&#x003b1;</italic>, <italic toggle="yes">IL-1&#x003b2;</italic>, <italic toggle="yes">IL-6</italic>, <italic toggle="yes">IL-10</italic>, <italic toggle="yes">TNF&#x003b1;</italic>, <italic toggle="yes">NCF4</italic>, <italic toggle="yes">NFKB</italic>, <italic toggle="yes">TMED</italic>, <italic toggle="yes">FCAMR</italic>, <italic toggle="yes">iNOS</italic> and <italic toggle="yes">COX18</italic>. The rams suffering from arthritis exhibited abnormally low levels of gene expression for <italic toggle="yes">SOD3</italic>, <italic toggle="yes">CAT</italic>, <italic toggle="yes">GPX</italic> and <italic toggle="yes">ATOX1</italic>. No study has ever looked at the amounts of antioxidant and immunological markers in sheep transcripts in relation to arthritis. Consequently, quantitative changes in the expression of the relevant genes occur prior to the development of arthritis.</p><p>This research described the antioxidant (<italic toggle="yes">SOD3</italic>, <italic toggle="yes">CAT</italic>, <italic toggle="yes">GPX</italic>, <italic toggle="yes">ATOX1</italic> and <italic toggle="yes">COX18</italic>) and immunological (<italic toggle="yes">IL-1&#x003b1;</italic>, <italic toggle="yes">IL-1&#x003b2;</italic>, <italic toggle="yes">IL-6</italic>, <italic toggle="yes">IL-10</italic>, <italic toggle="yes">TNF&#x003b1;</italic>, <italic toggle="yes">NCF4</italic>, <italic toggle="yes">NFKB</italic>, <italic toggle="yes">TMED</italic>, <italic toggle="yes">FCAMR</italic> and <italic toggle="yes">iNOS</italic>) genes in rams that had arthritis and those that did not. The PCR-DNA sequencing method was utilized for this purpose. The findings point to variations in the SNPs affecting the two groups. It is worth noting that the polymorphisms found and made available in this context provide more information for the evaluated metrics compared to similar datasets collected from GenBank. No studies have investigated whether or not single-nucleotide polymorphisms (SNPs) in antioxidant and immunological genes increase the incidence of arthritis in sheep. The gene sequences of <italic toggle="yes">Ovis aries</italic>, which were published in PubMed as part of our study, are the first to demonstrate this association.</p><p>Indirect indicators of inflammation include cytokines such as NFKB, IL-1&#x003b1;, TNF-&#x003b1;, IFN-H, IL-1B and IL-6 [<xref rid="B27-vetsci-12-00122" ref-type="bibr">27</xref>]. Macrophages inhibit the NK cell production of IL-1 and TNF, while the anti-inflammatory cytokine IL-10 stops Th1 lymphocytes from making IFN- and IL-2 [<xref rid="B28-vetsci-12-00122" ref-type="bibr">28</xref>,<xref rid="B29-vetsci-12-00122" ref-type="bibr">29</xref>]. The reason why there is a noticeable rise in the number of uterine washings performed on cows with subclinical endometritis could be because IL-10, which is produced by different types of T-cells, has anti-inflammatory properties. These properties protect the uterine tissues from the harmful effects of inflammatory cells and mediators through its interaction with suppressor T CD8+ cells [<xref rid="B30-vetsci-12-00122" ref-type="bibr">30</xref>]. However, IL-10 has been associated with inflammation, protracted postpartum infection and damage to uterine local resistance [<xref rid="B31-vetsci-12-00122" ref-type="bibr">31</xref>]. It appears that the innate immunity gene neutrophil cytosolic factor 4 (NCF4) is associated with and has an effect on mastitis in cattle [<xref rid="B32-vetsci-12-00122" ref-type="bibr">32</xref>].</p><p>One member of the family of transmembrane proteins that transport proteins across vesicles is known as transmembrane P24 trafficking protein 1 (TMED1) [<xref rid="B33-vetsci-12-00122" ref-type="bibr">33</xref>]. In goats, the <italic toggle="yes">TMED1</italic> gene has shown a significant increase in expression in kids with diarrhea compared to those without diarrhea [<xref rid="B34-vetsci-12-00122" ref-type="bibr">34</xref>]. It is possible that FCAMR is involved in the immunological response to microbes mediated by IgA and IgM [<xref rid="B35-vetsci-12-00122" ref-type="bibr">35</xref>]. Ewes with endometritis had a marked increase in the expression of the <italic toggle="yes">FCAMR</italic> gene [<xref rid="B35-vetsci-12-00122" ref-type="bibr">35</xref>]. From the amino acid L-arginine, nitric oxide (NO) is produced by nitric oxide synthase (NOS). NO is crucial for many physiological and pathological processes. The transcription of the <italic toggle="yes">NOS2A</italic> gene, which encodes iNOS, is regulated by inflammatory mediators released by immunocompetent cells such as macrophages and neutrophils [<xref rid="B36-vetsci-12-00122" ref-type="bibr">36</xref>].</p><p>Antioxidants can shield us from harm by removing reactive oxygen species (ROS) from the air, blocking their production or preserving transition metals, which are essential for free radical production [<xref rid="B37-vetsci-12-00122" ref-type="bibr">37</xref>]. Catalase (CAT) and superoxide dismutase (SOD), which are the body&#x02019;s own enzymatic and non-enzymatic antioxidant defenses, are known as endogenous antioxidant markers [<xref rid="B38-vetsci-12-00122" ref-type="bibr">38</xref>]. Mitochondrial cytochrome c oxidase assembly components are encoded by the <italic toggle="yes">COX18</italic> gene and are necessary for the insertion of integral membrane proteins into the inner mitochondrial membrane. It plays an essential role in cytochrome c oxidase assembly and function as well [<xref rid="B39-vetsci-12-00122" ref-type="bibr">39</xref>]. The <italic toggle="yes">COX18</italic> gene was much less expressed in cows with mastitis as compared to healthy Holstein and Montb&#x000e9;liarde dairy cows [<xref rid="B40-vetsci-12-00122" ref-type="bibr">40</xref>].</p><p>Pathogen invasion may be a potent oxidizing stimulus that sets off immunological responses to counter the pathogen onslaught by boosting the activity of neutrophils and macrophages. This leads to the production and accumulation of an excessive amount of ROS, which ultimately results in oxidative stress [<xref rid="B6-vetsci-12-00122" ref-type="bibr">6</xref>]. The considerable change in the expression configuration of antioxidant (<italic toggle="yes">SOD3</italic>, <italic toggle="yes">CAT</italic>, <italic toggle="yes">GPX</italic>, <italic toggle="yes">ATOX1</italic> and <italic toggle="yes">COX18</italic>) and immunological (<italic toggle="yes">IL-1&#x003b1;</italic>, <italic toggle="yes">IL-1&#x003b2;</italic>, <italic toggle="yes">IL-6</italic>, <italic toggle="yes">IL-10</italic>, <italic toggle="yes">TNF&#x003b1;</italic>, <italic toggle="yes">NCF4</italic>, <italic toggle="yes">NFKB</italic>, <italic toggle="yes">TMED</italic>, <italic toggle="yes">FCAMR</italic> and <italic toggle="yes">iNOS</italic>) indicators in rams with arthritis may be explained by the previously described factors. Therefore, we believe that the arthritis in the rams in the study is caused by an infectious etiology. Our real-time PCR data revealed that the rams with arthritis also displayed a significant inflammatory response.</p><p>Cytokines are significant inflammatory response modulators. It is possible to classify these glycoprotein molecules as either pro- or anti-inflammatory. When infections occur, pro-inflammatory cytokines are released quickly, alerting immune cells to start and spread the immune response [<xref rid="B14-vetsci-12-00122" ref-type="bibr">14</xref>,<xref rid="B15-vetsci-12-00122" ref-type="bibr">15</xref>,<xref rid="B41-vetsci-12-00122" ref-type="bibr">41</xref>]. Conversely, anti-inflammatory cytokines regulate and resolve inflammatory actions, preventing excessive damage. In this study, the observed upregulation of pro-inflammatory cytokines and downregulation of anti-inflammatory cytokines in the AG corresponded to an exacerbated inflammatory response. These findings align with previous reports [<xref rid="B14-vetsci-12-00122" ref-type="bibr">14</xref>,<xref rid="B15-vetsci-12-00122" ref-type="bibr">15</xref>,<xref rid="B16-vetsci-12-00122" ref-type="bibr">16</xref>,<xref rid="B41-vetsci-12-00122" ref-type="bibr">41</xref>], which documented elevated systemic and local pro-inflammatory cytokines and diminished anti-inflammatory cytokines in arthritis, triggering joint damage, impaired mobility and functional decline. Targeting pro-inflammatory cytokines has been recommended as a therapeutic approach to mitigate chronic-arthritis-induced damage [<xref rid="B42-vetsci-12-00122" ref-type="bibr">42</xref>].</p><p>APPs are non-specific innate immune molecules that are rapidly secreted into circulation during infection and surgery and persist in the blood for a long time [<xref rid="B43-vetsci-12-00122" ref-type="bibr">43</xref>]. Their pronounced increment in the AG in our research was necessary to maintain body homeostasis and limit microbial growth until the synthesis of immunoglobulins. In addition, they have potent anti-inflammatory, anti-bacterial and antioxidant actions [<xref rid="B44-vetsci-12-00122" ref-type="bibr">44</xref>]. These findings were concurrent with previous studies that suggested APPs as an auxiliary tool in the diagnosis of different diseases in ruminants [<xref rid="B44-vetsci-12-00122" ref-type="bibr">44</xref>,<xref rid="B45-vetsci-12-00122" ref-type="bibr">45</xref>]. According to [<xref rid="B46-vetsci-12-00122" ref-type="bibr">46</xref>], the pronounced acute-phase reactant levels were useful for disease activity evaluations and predictions of outcomes.</p><p>Another important factor is free radicals, which are extremely reactive chemicals created during immunological reactions. In order to neutralize pathogens, they oxidize vital components such as DNA and proteins [<xref rid="B47-vetsci-12-00122" ref-type="bibr">47</xref>]. In the current work, the AG showed significant oxidative stress, which is defined by an excess of free radicals, a depletion of antioxidants and subsequent damage to chondrocytes and other tissues. Similar oxidative imbalances have been reported in both animal and human inflammatory diseases, including arthritis [<xref rid="B6-vetsci-12-00122" ref-type="bibr">6</xref>,<xref rid="B24-vetsci-12-00122" ref-type="bibr">24</xref>,<xref rid="B48-vetsci-12-00122" ref-type="bibr">48</xref>].</p><p>As a key component of immune defense, the complement system facilitates tissue repair, immune complex clearance and antigen recognition [<xref rid="B25-vetsci-12-00122" ref-type="bibr">25</xref>,<xref rid="B49-vetsci-12-00122" ref-type="bibr">49</xref>]. This study&#x02019;s notable decrease in C3 and C4 levels in the AG suggested chronic inflammation and hyperactivation of the complement system, which is responsible for consuming complement system proteins [<xref rid="B27-vetsci-12-00122" ref-type="bibr">27</xref>]. There is no doubt that this complement element deficiency worsens the conditions of the rams in the AG group and predisposes them to other infections and inflammatory disorders [<xref rid="B28-vetsci-12-00122" ref-type="bibr">28</xref>]. However, this study&#x02019;s increased levels of IgA, IgM and IgG in the AG suggest a strong humoral response powered by pro-inflammatory cytokines [<xref rid="B29-vetsci-12-00122" ref-type="bibr">29</xref>]. These results support the use of immunoglobulin titers to assess the course and activity of disease [<xref rid="B30-vetsci-12-00122" ref-type="bibr">30</xref>]. Similarly, [<xref rid="B29-vetsci-12-00122" ref-type="bibr">29</xref>] and [<xref rid="B30-vetsci-12-00122" ref-type="bibr">30</xref>] recorded raised serum IgA, IgM and IgG in arthritic patients.</p><p>The current study found that different endocrine responses are triggered by arthritis. Serum levels of cortisol, growth hormone (GH) and thyroid-stimulating hormone (TSH) were higher in animals with arthritis (AG), whereas serum levels of insulin, triiodothyronine (T3) and thyroxine (T4) were lower. These hormonal changes are comparable to those seen in other inflammatory conditions [<xref rid="B31-vetsci-12-00122" ref-type="bibr">31</xref>,<xref rid="B32-vetsci-12-00122" ref-type="bibr">32</xref>]. The primary cause of the observed alterations is hypoglycemia, which is a prevalent characteristic of inflammatory conditions like arthritis. Significant energy is required for pro-inflammatory activation and immune responses, which causes marked hypoglycemia in afflicted animals. In order to combat hypoglycemia, energy-regulating glands, especially the pituitary gland, become active and secrete more growth hormone (GH) and adrenocorticotropic hormone (ACTH) [<xref rid="B33-vetsci-12-00122" ref-type="bibr">33</xref>,<xref rid="B34-vetsci-12-00122" ref-type="bibr">34</xref>]. The adrenal glands are stimulated by ACTH to release cortisol into the bloodstream [<xref rid="B33-vetsci-12-00122" ref-type="bibr">33</xref>,<xref rid="B34-vetsci-12-00122" ref-type="bibr">34</xref>]. Cortisol and GH both lower the cell uptake of glucose, which leads to hyperglycemia. Furthermore, cortisol causes hyperglycemia by suppressing thyroid gland T3 and T4 secretion, increasing hepatic glycogenolysis and gluconeogenesis and encouraging insulin resistance [<xref rid="B31-vetsci-12-00122" ref-type="bibr">31</xref>,<xref rid="B32-vetsci-12-00122" ref-type="bibr">32</xref>]. Concurrently, pancreatic beta cells decrease insulin synthesis in response to hypoglycemia, which further reduces the cell uptake of glucose [<xref rid="B31-vetsci-12-00122" ref-type="bibr">31</xref>,<xref rid="B32-vetsci-12-00122" ref-type="bibr">32</xref>]. Consequently, the arthritis group (AG) in this study showed significant hypercortisolemia, hyperinsulinemia, decreased T3 and T4 levels and increased GH levels. The increased TSH levels in AG are likely a compensatory response by the pituitary gland to the reduced serum concentrations of T3 and T4 [<xref rid="B31-vetsci-12-00122" ref-type="bibr">31</xref>,<xref rid="B32-vetsci-12-00122" ref-type="bibr">32</xref>]. These results demonstrate a synchronized hormonal response intended to maintain immunological function in inflammatory conditions, improve gluconeogenesis and counteract hypoglycemia [<xref rid="B31-vetsci-12-00122" ref-type="bibr">31</xref>,<xref rid="B32-vetsci-12-00122" ref-type="bibr">32</xref>,<xref rid="B33-vetsci-12-00122" ref-type="bibr">33</xref>,<xref rid="B34-vetsci-12-00122" ref-type="bibr">34</xref>].</p><p>This study&#x02019;s iron profile for the AG showed significant changes in iron metabolism such as hypoferremia, hyperferritinemia and hypotransferrinemia. The authors of [<xref rid="B35-vetsci-12-00122" ref-type="bibr">35</xref>,<xref rid="B36-vetsci-12-00122" ref-type="bibr">36</xref>] discovered similar alterations in rheumatoid arthritis (RA) patients&#x02019; iron profiles. They reasoned that the inflammatory immune response that accompanied the illness was responsible for these changes. However, activated pro-inflammatory cytokines reduce iron bioavailability by promoting ferritin storage, releasing hepcidin, which prevents the intestinal absorption of iron, and reducing transferrin activity, which prevents infections from spreading [<xref rid="B14-vetsci-12-00122" ref-type="bibr">14</xref>,<xref rid="B15-vetsci-12-00122" ref-type="bibr">15</xref>,<xref rid="B41-vetsci-12-00122" ref-type="bibr">41</xref>]. In chronic inflammatory circumstances, its activity can produce anemic swings in unhealthy people, despite its antimicrobial properties [<xref rid="B14-vetsci-12-00122" ref-type="bibr">14</xref>,<xref rid="B15-vetsci-12-00122" ref-type="bibr">15</xref>,<xref rid="B41-vetsci-12-00122" ref-type="bibr">41</xref>]. Similarly to how ferritin is a positive acute-phase protein and transferrin is a negative one, these alterations were also influenced by the acute-phase response that was shown in the AG [<xref rid="B44-vetsci-12-00122" ref-type="bibr">44</xref>,<xref rid="B45-vetsci-12-00122" ref-type="bibr">45</xref>]. In addition, the host erythrocytes are attacked by oxidative stress and unregulated free radicals throughout the disease course, leading to their lysis and excess iron release. The oxidative action of free iron causes the body to boost ferritin synthesis as a defense mechanism [<xref rid="B24-vetsci-12-00122" ref-type="bibr">24</xref>,<xref rid="B48-vetsci-12-00122" ref-type="bibr">48</xref>]. In a logical sense, the exceptional hypoferremia caused TIBC and UIBC to rise while the Tf sat.% in the AG fell.</p><p>According to <xref rid="vetsci-12-00122-t004" ref-type="table">Table 4</xref>, APPs and estimated pro-inflammatory cytokines in ovine arthritis can be used as biomarkers for sheep arthritis, particularly IL-1&#x003b1;, IL-6, TNF-&#x003b1; and Hp, which had the best specificity, LR, PPV and accuracy rates. But out of all of them, Hp was given precedence due to the degree of its increase. Several writers have already found similar results in various animal and human diseases. They validated the significance of pro-inflammatory cytokines and APPs in the diagnosis and monitoring of inflammatory disorders [<xref rid="B14-vetsci-12-00122" ref-type="bibr">14</xref>,<xref rid="B15-vetsci-12-00122" ref-type="bibr">15</xref>,<xref rid="B16-vetsci-12-00122" ref-type="bibr">16</xref>,<xref rid="B41-vetsci-12-00122" ref-type="bibr">41</xref>].</p><p>Our study was limited by the lack of arthrocentesis in the afflicted joints to evaluate the cause of joint inflammation, identify the content of inflammatory infiltrates and measure the viscosity and turbidity of the synovial fluid. Therefore, future research must consider arthrocentesis in the affected joints.</p></sec><sec sec-type="conclusions" id="sec5-vetsci-12-00122"><title>5. Conclusions</title><p>Our findings highlight the significance of the nucleotide sequence variation and expression profiles of the inspected immune and antioxidant genes as predisposing factors and monitors their relationship to arthritis predisposition in sheep. It can also be concluded that ovine arthritis evokes innate as well as humeral immunity. The pro-inflammatory cytokines, APPs, antioxidants, hormonal assays and iron profile changes are a reflection of the immune response in sheep with arthritis.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors extend their appreciation to the Deanship of Research and Graduate Studies at King Khalid University for funding this work through the Large Research Project under grant number RGP2/312/45.</p></ack><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><app-group><app id="app1-vetsci-12-00122"><title>Supplementary Materials</title><p>The following supporting information can be downloaded at: <uri xlink:href="https://www.mdpi.com/article/10.3390/vetsci12020122/s1">https://www.mdpi.com/article/10.3390/vetsci12020122/s1</uri>, Figure S1: Representative Sequence alignment of <italic toggle="yes">IL-1&#x003b1;</italic> gene (466 bp) between healthy (H), and arthritis (A) rams. Figure S2: Representative Sequence alignment of <italic toggle="yes">IL-1&#x003b2;</italic> gene (361 bp) between healthy (H), and arthritis (A) rams. Figure S3: Representative Sequence alignment of <italic toggle="yes">IL-6</italic> gene (370 bp) between healthy (H), and arthritis (A) rams. Figure S4: Representative Sequence alignment of <italic toggle="yes">TNF&#x003b1;</italic> gene (386 bp) between healthy (H), and arthritis (A) rams. Figure S5: Representative Sequence alignment of <italic toggle="yes">IL-10</italic> gene (387 bp) between healthy (H), and arthritis (A) rams. Figure S6: Representative Sequence alignment of <italic toggle="yes">NFKB</italic> gene (411 bp) between healthy (H), and arthritis (A) rams. Figure S7: Representative Sequence alignment of <italic toggle="yes">NCF4</italic> gene (345 bp) between healthy (H), and arthritis (A) rams. Figure S8: Representative Sequence alignment of <italic toggle="yes">TMED1</italic> gene (408 bp) between healthy (H), and arthritis (A) rams. Figure S9: Representative Sequence alignment of <italic toggle="yes">FCAMR</italic> gene (378 bp) between healthy (H), and arthritis (A) rams. Figure S10: Representative Sequence alignment of <italic toggle="yes">iNOS</italic> gene (480 bp) between healthy (H), and arthritis (A) rams. Figure S11: Representative Sequence alignment of <italic toggle="yes">SOD</italic> gene (381 bp) between healthy (H), and arthritis (A) rams. Figure S12: Representative Sequence alignment of <italic toggle="yes">CAT</italic> gene (473 bp) between healthy (H), and arthritis (A) rams. Figure S13: Representative Sequence alignment of <italic toggle="yes">GPX</italic> gene (416 bp) between healthy (H), and arthritis (A) rams. Figure S14: Representative Sequence alignment of <italic toggle="yes">ATOX1</italic> gene (430 bp) between healthy (H), and arthritis (A) rams. Figure S15: Representative Sequence alignment of <italic toggle="yes">COX18</italic> gene (415 bp) between healthy (H), and arthritis (A) rams.</p><supplementary-material id="vetsci-12-00122-s001" position="float" content-type="local-data"><media xlink:href="vetsci-12-00122-s001.zip"/></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>A.D. and A.E.-S. conceived of and designed the experiment, as well as collected blood samples. A.A. created the study report, conducted the PCR tests and planned the experiment. M.A.A. analyzed the data and contributed to the writing of the manuscript. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>The Ethics Committee of Desert Research Centre (DRC), Egypt, approved the methods used to collect the samples and the care of the animals in this experiment (code DRC-021-1-23).</p></notes><notes><title>Informed Consent Statement</title><p>Every farmer consented to the study after being fully informed.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>Upon reasonable request, the appropriate author will share supporting data for the study&#x02019;s conclusions.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><ref-list><title>References</title><ref id="B1-vetsci-12-00122"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jesse</surname><given-names>F.F.A.</given-names></name>
<name><surname>B&#x00131;trus</surname><given-names>A.</given-names></name>
<name><surname>Abba</surname><given-names>Y.</given-names></name>
<name><surname>Mahadzar</surname><given-names>M.</given-names></name>
<name><surname>Hambal&#x00131;</surname><given-names>I.</given-names></name>
<name><surname>Peter</surname><given-names>I.</given-names></name>
<name><surname>Haron</surname><given-names>A.</given-names></name>
<name><surname>L&#x00131;la</surname><given-names>M.</given-names></name>
<name><surname>Saharee</surname><given-names>A.</given-names></name>
</person-group><article-title>Clinical management of septic arthritis in a sheep: A case report</article-title><source>Adv. Anim. Vet. Sci.</source><year>2017</year><volume>5</volume><fpage>267</fpage><lpage>270</lpage></element-citation></ref><ref id="B2-vetsci-12-00122"><label>2.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Kamilo&#x0011f;lu</surname><given-names>A.</given-names></name>
</person-group><source>&#x000c7;iftlik Hayvanlar&#x00131;nda ayak Hastal&#x00131;klar&#x00131;</source><publisher-name>Medipress Yay&#x00131;nc&#x00131;l&#x00131;k</publisher-name><publisher-loc>Lisans, T&#x000fc;rkiye</publisher-loc><year>2014</year></element-citation></ref><ref id="B3-vetsci-12-00122"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Desrochers</surname><given-names>A.</given-names></name>
<name><surname>St Jean</surname><given-names>G.</given-names></name>
</person-group><article-title>Surgical management of digit disorders in cattle</article-title><source>Vet. Clin. N. Am. Food Anim. Pract.</source><year>1996</year><volume>12</volume><fpage>277</fpage><lpage>298</lpage><pub-id pub-id-type="doi">10.1016/S0749-0720(15)30448-5</pub-id><pub-id pub-id-type="pmid">8705807</pub-id>
</element-citation></ref><ref id="B4-vetsci-12-00122"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Desrochers</surname><given-names>A.</given-names></name>
<name><surname>Francoz</surname><given-names>D.</given-names></name>
</person-group><article-title>Clinical management of septic arthritis in cattle</article-title><source>Vet. Clin. Food Anim. Pract.</source><year>2014</year><volume>30</volume><fpage>177</fpage><lpage>203</lpage><pub-id pub-id-type="doi">10.1016/j.cvfa.2013.11.006</pub-id></element-citation></ref><ref id="B5-vetsci-12-00122"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mulon</surname><given-names>P.-Y.</given-names></name>
<name><surname>Desrochers</surname><given-names>A.</given-names></name>
<name><surname>Francoz</surname><given-names>D.</given-names></name>
</person-group><article-title>Surgical management of septic arthritis</article-title><source>Vet. Clin. Food Anim. Pract.</source><year>2016</year><volume>32</volume><fpage>777</fpage><lpage>795</lpage><pub-id pub-id-type="doi">10.1016/j.cvfa.2016.05.014</pub-id></element-citation></ref><ref id="B6-vetsci-12-00122"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yurdakul</surname><given-names>&#x00130;.</given-names></name>
</person-group><article-title>Evaluation of clinical, radiological, ultrasonographic and microbiological findings of septic arthritis in 50 calves</article-title><source>Rev. Mex. De Cienc. Pecu.</source><year>2019</year><volume>10</volume><fpage>254</fpage><lpage>266</lpage><pub-id pub-id-type="doi">10.22319/rmcp.v10i1.4727</pub-id></element-citation></ref><ref id="B7-vetsci-12-00122"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Khalid</surname><given-names>A.</given-names></name>
<name><surname>Na</surname><given-names>Y.</given-names></name>
<name><surname>Jinyou</surname><given-names>Z.</given-names></name>
<name><surname>Khudhair</surname><given-names>N.</given-names></name>
<name><surname>Guixue</surname><given-names>Z.</given-names></name>
</person-group><article-title>Responses of Chicken Sertoli Cells and Fibroblasts after Transfection with Plasmids pEGFP-N3-HNP-1</article-title><source>Pak. Vet. J.</source><year>2015</year><volume>35</volume><fpage>504</fpage></element-citation></ref><ref id="B8-vetsci-12-00122"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Iliev</surname><given-names>P.</given-names></name>
<name><surname>Georgieva</surname><given-names>T.</given-names></name>
</person-group><article-title>Acute phase biomarkers of diseases in small ruminants: An overview</article-title><source>Bulg. J. Vet. Med.</source><year>2019</year><volume>22</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.15547/10.15547/bjvm.1051</pub-id></element-citation></ref><ref id="B9-vetsci-12-00122"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ceciliani</surname><given-names>F.</given-names></name>
<name><surname>Ceron</surname><given-names>J.</given-names></name>
<name><surname>Eckersall</surname><given-names>P.</given-names></name>
<name><surname>Sauerwein</surname><given-names>H.</given-names></name>
</person-group><article-title>Acute phase proteins in ruminants</article-title><source>J. Proteom.</source><year>2012</year><volume>75</volume><fpage>4207</fpage><lpage>4231</lpage><pub-id pub-id-type="doi">10.1016/j.jprot.2012.04.004</pub-id></element-citation></ref><ref id="B10-vetsci-12-00122"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Miglio</surname><given-names>A.</given-names></name>
<name><surname>Moscati</surname><given-names>L.</given-names></name>
<name><surname>Scoccia</surname><given-names>E.</given-names></name>
<name><surname>Maresca</surname><given-names>C.</given-names></name>
<name><surname>Antognoni</surname><given-names>M.T.</given-names></name>
<name><surname>Felici</surname><given-names>A.</given-names></name>
</person-group><article-title>Reference values for serum amyloid A, haptoglobin, lysozyme, zinc and iron in healthy lactating Lacaune sheep</article-title><source>Acta Vet. Scand.</source><year>2018</year><volume>60</volume><fpage>1</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1186/s13028-018-0400-x</pub-id><pub-id pub-id-type="pmid">29298694</pub-id>
</element-citation></ref><ref id="B11-vetsci-12-00122"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sharma</surname><given-names>N.</given-names></name>
<name><surname>Singh</surname><given-names>N.</given-names></name>
<name><surname>Singh</surname><given-names>O.</given-names></name>
<name><surname>Pandey</surname><given-names>V.</given-names></name>
<name><surname>Verma</surname><given-names>P.</given-names></name>
</person-group><article-title>Oxidative stress and antioxidant status during transition period in dairy cows</article-title><source>Asian-Australas. J. Anim. Sci.</source><year>2011</year><volume>24</volume><fpage>479</fpage><lpage>484</lpage><pub-id pub-id-type="doi">10.5713/ajas.2011.10220</pub-id></element-citation></ref><ref id="B12-vetsci-12-00122"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Surai</surname><given-names>P.F.</given-names></name>
<name><surname>Earle-Payne</surname><given-names>K.</given-names></name>
</person-group><article-title>Antioxidant defences and redox homeostasis in animals</article-title><source>Antioxidants</source><year>2022</year><volume>11</volume><elocation-id>1012</elocation-id><pub-id pub-id-type="doi">10.3390/antiox11051012</pub-id><pub-id pub-id-type="pmid">35624875</pub-id>
</element-citation></ref><ref id="B13-vetsci-12-00122"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mohamed</surname><given-names>R.H.</given-names></name>
<name><surname>Khalphallah</surname><given-names>A.</given-names></name>
<name><surname>Nakada</surname><given-names>K.</given-names></name>
<name><surname>Elmeligy</surname><given-names>E.</given-names></name>
<name><surname>Hassan</surname><given-names>D.</given-names></name>
<name><surname>Ebissy</surname><given-names>E.A.</given-names></name>
<name><surname>Ghandour</surname><given-names>R.A.</given-names></name>
<name><surname>Mousa</surname><given-names>S.A.</given-names></name>
<name><surname>Hassaneen</surname><given-names>A.S.</given-names></name>
</person-group><article-title>Clinical and correlated responses among steroid hormones and oxidant/antioxidant biomarkers in pregnant, non-pregnant and lactating CIDR-pre-synchronized dromedaries (<italic toggle="yes">Camelus dromedarius</italic>)</article-title><source>Vet. Sci.</source><year>2021</year><volume>8</volume><elocation-id>247</elocation-id><pub-id pub-id-type="doi">10.3390/vetsci8110247</pub-id><pub-id pub-id-type="pmid">34822620</pub-id>
</element-citation></ref><ref id="B14-vetsci-12-00122"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>C.</given-names></name>
</person-group><article-title>Flare-up of cytokines in rheumatoid arthritis and their role in triggering depression: Shared common function and their possible applications in treatment</article-title><source>Biomed. Rep.</source><year>2021</year><volume>14</volume><elocation-id>16</elocation-id><pub-id pub-id-type="doi">10.3892/br.2020.1392</pub-id><pub-id pub-id-type="pmid">33269077</pub-id>
</element-citation></ref><ref id="B15-vetsci-12-00122"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kondo</surname><given-names>N.</given-names></name>
<name><surname>Kuroda</surname><given-names>T.</given-names></name>
<name><surname>Kobayashi</surname><given-names>D.</given-names></name>
</person-group><article-title>Cytokine networks in the pathogenesis of rheumatoid arthritis</article-title><source>Int. J. Mol. Sci.</source><year>2021</year><volume>22</volume><elocation-id>10922</elocation-id><pub-id pub-id-type="doi">10.3390/ijms222010922</pub-id><pub-id pub-id-type="pmid">34681582</pub-id>
</element-citation></ref><ref id="B16-vetsci-12-00122"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>Z.</given-names></name>
<name><surname>Bozec</surname><given-names>A.</given-names></name>
<name><surname>Ramming</surname><given-names>A.</given-names></name>
<name><surname>Schett</surname><given-names>G.</given-names></name>
</person-group><article-title>Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis</article-title><source>Nat. Rev. Rheumatol.</source><year>2019</year><volume>15</volume><fpage>9</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1038/s41584-018-0109-2</pub-id><pub-id pub-id-type="pmid">30341437</pub-id>
</element-citation></ref><ref id="B17-vetsci-12-00122"><label>17.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Pugh</surname><given-names>D.</given-names></name>
</person-group><source>Sheep and Goat Medicine</source><edition>2nd ed.</edition><person-group person-group-type="editor">
<name><surname>Pugh</surname><given-names>D.G.</given-names></name>
<name><surname>Baird</surname><given-names>A.N.</given-names></name>
</person-group><publisher-name>Elsevier</publisher-name><publisher-loc>Amsterdam, The Netherlands</publisher-loc><year>2012</year><comment>Available online: <ext-link xlink:href="https://www.elsevier.com" ext-link-type="uri">https://www.elsevier.com</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2024-12-24">(accessed on 24 December 2024)</date-in-citation></element-citation></ref><ref id="B18-vetsci-12-00122"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pfaffl</surname><given-names>M.W.</given-names></name>
</person-group><article-title>A new mathematical model for relative quantification in real-time RT&#x02013;PCR</article-title><source>Nucleic Acids Res.</source><year>2001</year><volume>29</volume><fpage>e45</fpage><pub-id pub-id-type="doi">10.1093/nar/29.9.e45</pub-id><pub-id pub-id-type="pmid">11328886</pub-id>
</element-citation></ref><ref id="B19-vetsci-12-00122"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Darwish</surname><given-names>A.</given-names></name>
<name><surname>Ebissy</surname><given-names>E.</given-names></name>
<name><surname>Hafez</surname><given-names>A.</given-names></name>
<name><surname>Ateya</surname><given-names>A.</given-names></name>
<name><surname>El-Sayed</surname><given-names>A.</given-names></name>
</person-group><article-title>Nucleotide sequence variants, gene expression and serum profile of immune and antioxidant markers associated with bacterial diarrhea susceptibility in Barki lambs</article-title><source>BMC Vet. Res.</source><year>2024</year><volume>20</volume><elocation-id>462</elocation-id><pub-id pub-id-type="doi">10.1186/s12917-024-04288-1</pub-id><pub-id pub-id-type="pmid">39394128</pub-id>
</element-citation></ref><ref id="B20-vetsci-12-00122"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Boesenberg-Smith</surname><given-names>K.A.</given-names></name>
<name><surname>Pessarakli</surname><given-names>M.M.</given-names></name>
<name><surname>Wolk</surname><given-names>D.M.</given-names></name>
</person-group><article-title>Assessment of DNA yield and purity: An overlooked detail of PCR troubleshooting</article-title><source>Clin. Microbiol. Newsl.</source><year>2012</year><volume>34</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/j.clinmicnews.2011.12.002</pub-id></element-citation></ref><ref id="B21-vetsci-12-00122"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chu</surname><given-names>Y.-C.</given-names></name>
<name><surname>Yu</surname><given-names>K.-H.</given-names></name>
<name><surname>Lin</surname><given-names>W.-T.</given-names></name>
<name><surname>Wang</surname><given-names>W.-T.</given-names></name>
<name><surname>Chen</surname><given-names>D.-P.</given-names></name>
</person-group><article-title>Finding the Common Single-Nucleotide Polymorphisms in Three Autoimmune Diseases and Exploring Their Bio-Function by Using a Reporter Assay</article-title><source>Biomedicines</source><year>2023</year><volume>11</volume><elocation-id>2426</elocation-id><pub-id pub-id-type="doi">10.3390/biomedicines11092426</pub-id><pub-id pub-id-type="pmid">37760867</pub-id>
</element-citation></ref><ref id="B22-vetsci-12-00122"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Essa</surname><given-names>B.</given-names></name>
<name><surname>Al-Sharif</surname><given-names>M.</given-names></name>
<name><surname>Abdo</surname><given-names>M.</given-names></name>
<name><surname>Fericean</surname><given-names>L.</given-names></name>
<name><surname>Ateya</surname><given-names>A.</given-names></name>
</person-group><article-title>New insights on nucleotide sequence variants and mRNA levels of candidate genes assessing resistance/susceptibility to mastitis in Holstein and Montb&#x000e9;liarde dairy cows</article-title><source>Vet. Sci.</source><year>2023</year><volume>10</volume><elocation-id>35</elocation-id><pub-id pub-id-type="doi">10.3390/vetsci10010035</pub-id><pub-id pub-id-type="pmid">36669036</pub-id>
</element-citation></ref><ref id="B23-vetsci-12-00122"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tamura</surname><given-names>K.</given-names></name>
<name><surname>Stecher</surname><given-names>G.</given-names></name>
<name><surname>Peterson</surname><given-names>D.</given-names></name>
<name><surname>Filipski</surname><given-names>A.</given-names></name>
<name><surname>Kumar</surname><given-names>S.</given-names></name>
</person-group><article-title>MEGA6: Molecular evolutionary genetics analysis version 6.0</article-title><source>Mol. Biol. Evol.</source><year>2013</year><volume>30</volume><fpage>2725</fpage><lpage>2729</lpage><pub-id pub-id-type="doi">10.1093/molbev/mst197</pub-id><pub-id pub-id-type="pmid">24132122</pub-id>
</element-citation></ref><ref id="B24-vetsci-12-00122"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Forman</surname><given-names>H.J.</given-names></name>
<name><surname>Zhang</surname><given-names>H.</given-names></name>
</person-group><article-title>Targeting oxidative stress in disease: Promise and limitations of antioxidant therapy</article-title><source>Nat. Rev. Drug Discov.</source><year>2021</year><volume>20</volume><fpage>689</fpage><lpage>709</lpage><pub-id pub-id-type="doi">10.1038/s41573-021-00233-1</pub-id><pub-id pub-id-type="pmid">34194012</pub-id>
</element-citation></ref><ref id="B25-vetsci-12-00122"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Assirelli</surname><given-names>E.</given-names></name>
<name><surname>Pulsatelli</surname><given-names>L.</given-names></name>
<name><surname>Dolzani</surname><given-names>P.</given-names></name>
<name><surname>Mariani</surname><given-names>E.</given-names></name>
<name><surname>Lisignoli</surname><given-names>G.</given-names></name>
<name><surname>Addimanda</surname><given-names>O.</given-names></name>
<name><surname>Meliconi</surname><given-names>R.</given-names></name>
</person-group><article-title>Complement expression and activation in osteoarthritis joint compartments</article-title><source>Front. Immunol.</source><year>2020</year><volume>11</volume><elocation-id>535010</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2020.535010</pub-id><pub-id pub-id-type="pmid">33193305</pub-id>
</element-citation></ref><ref id="B26-vetsci-12-00122"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Walker</surname><given-names>E.</given-names></name>
<name><surname>Moore</surname><given-names>C.</given-names></name>
<name><surname>Shearer</surname><given-names>P.</given-names></name>
<name><surname>Jelocnik</surname><given-names>M.</given-names></name>
<name><surname>Bommana</surname><given-names>S.</given-names></name>
<name><surname>Timms</surname><given-names>P.</given-names></name>
<name><surname>Polkinghorne</surname><given-names>A.</given-names></name>
</person-group><article-title>Clinical, diagnostic and pathologic features of presumptive cases of Chlamydia pecorum-associated arthritis in Australian sheep flocks</article-title><source>BMC Vet. Res.</source><year>2016</year><volume>12</volume><elocation-id>193</elocation-id><pub-id pub-id-type="doi">10.1186/s12917-016-0832-3</pub-id><pub-id pub-id-type="pmid">27608808</pub-id>
</element-citation></ref><ref id="B27-vetsci-12-00122"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ballanti</surname><given-names>E.</given-names></name>
<name><surname>Perricone</surname><given-names>C.</given-names></name>
<name><surname>di Muzio</surname><given-names>G.</given-names></name>
<name><surname>Kroegler</surname><given-names>B.</given-names></name>
<name><surname>Chimenti</surname><given-names>M.S.</given-names></name>
<name><surname>Graceffa</surname><given-names>D.</given-names></name>
<name><surname>Perricone</surname><given-names>R.</given-names></name>
</person-group><article-title>Role of the complement system in rheumatoid arthritis and psoriatic arthritis: Relationship with anti-TNF inhibitors</article-title><source>Autoimmun. Rev.</source><year>2011</year><volume>10</volume><fpage>617</fpage><lpage>623</lpage><pub-id pub-id-type="doi">10.1016/j.autrev.2011.04.012</pub-id><pub-id pub-id-type="pmid">21549221</pub-id>
</element-citation></ref><ref id="B28-vetsci-12-00122"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sturfelt</surname><given-names>G.</given-names></name>
<name><surname>Truedsson</surname><given-names>L.</given-names></name>
</person-group><article-title>Complement in the immunopathogenesis of rheumatic disease</article-title><source>Nat. Rev. Rheumatol.</source><year>2012</year><volume>8</volume><fpage>458</fpage><lpage>468</lpage><pub-id pub-id-type="doi">10.1038/nrrheum.2012.75</pub-id><pub-id pub-id-type="pmid">22664835</pub-id>
</element-citation></ref><ref id="B29-vetsci-12-00122"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Adhya</surname><given-names>S.</given-names></name>
<name><surname>CHAKRABORTY</surname><given-names>G.</given-names></name>
<name><surname>Hajra</surname><given-names>B.</given-names></name>
<name><surname>Bhattacharya</surname><given-names>S.</given-names></name>
<name><surname>Sikdar</surname><given-names>P.</given-names></name>
<name><surname>Sinha</surname><given-names>S.</given-names></name>
<name><surname>Banerjee</surname><given-names>P.</given-names></name>
<name><surname>GHOSH</surname><given-names>E.</given-names></name>
<name><surname>Chakraborty</surname><given-names>P.</given-names></name>
</person-group><article-title>Serology and immunoglobulin profile in rheumatoid arthritis</article-title><source>Indian J. Pathol. Microbiol.</source><year>1998</year><volume>41</volume><fpage>43</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">9581076</pub-id>
</element-citation></ref><ref id="B30-vetsci-12-00122"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kim</surname><given-names>S.-H.</given-names></name>
<name><surname>Jeong</surname><given-names>H.-J.</given-names></name>
<name><surname>Kim</surname><given-names>J.-M.</given-names></name>
<name><surname>Jun</surname><given-names>J.-B.</given-names></name>
<name><surname>Son</surname><given-names>C.-N.</given-names></name>
</person-group><article-title>Clinical significance of elevated serum immunoglobulin G4 levels in patients with rheumatoid arthritis</article-title><source>J. Rheum. Dis.</source><year>2020</year><volume>27</volume><fpage>96</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.4078/jrd.2020.27.2.96</pub-id></element-citation></ref><ref id="B31-vetsci-12-00122"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Straub</surname><given-names>R.H.</given-names></name>
</person-group><article-title>Interaction of the endocrine system with inflammation: A function of energy and volume regulation</article-title><source>Arthritis Res. Ther.</source><year>2014</year><volume>16</volume><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1186/ar4684</pub-id></element-citation></ref><ref id="B32-vetsci-12-00122"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cruz-Topete</surname><given-names>D.</given-names></name>
<name><surname>Cidlowski</surname><given-names>J.A.</given-names></name>
</person-group><article-title>One hormone, two actions: Anti-and pro-inflammatory effects of glucocorticoids</article-title><source>Neuroimmunomodulation</source><year>2014</year><volume>22</volume><fpage>20</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1159/000362724</pub-id><pub-id pub-id-type="pmid">25227506</pub-id>
</element-citation></ref><ref id="B33-vetsci-12-00122"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yang</surname><given-names>C.</given-names></name>
<name><surname>Gao</surname><given-names>J.</given-names></name>
<name><surname>Du</surname><given-names>J.</given-names></name>
<name><surname>Yang</surname><given-names>X.</given-names></name>
<name><surname>Jiang</surname><given-names>J.</given-names></name>
</person-group><article-title>Altered neuroendocrine immune responses, a two-sword weapon against traumatic inflammation</article-title><source>Int. J. Biol. Sci.</source><year>2017</year><volume>13</volume><elocation-id>1409</elocation-id><pub-id pub-id-type="doi">10.7150/ijbs.21916</pub-id><pub-id pub-id-type="pmid">29209145</pub-id>
</element-citation></ref><ref id="B34-vetsci-12-00122"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>P&#x000e9;rez-Aguilar</surname><given-names>M.C.</given-names></name>
<name><surname>Rond&#x000f3;n-Mercado</surname><given-names>R.</given-names></name>
</person-group><article-title>Neuroimmunoendocrine system in health and disease</article-title><source>EC Microbiol.</source><year>2018</year><volume>14</volume><fpage>02</fpage><lpage>06</lpage></element-citation></ref><ref id="B35-vetsci-12-00122"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sato</surname><given-names>H.</given-names></name>
<name><surname>Takai</surname><given-names>C.</given-names></name>
<name><surname>Kazama</surname><given-names>J.J.</given-names></name>
<name><surname>Wakamatsu</surname><given-names>A.</given-names></name>
<name><surname>Hasegawa</surname><given-names>E.</given-names></name>
<name><surname>Kobayashi</surname><given-names>D.</given-names></name>
<name><surname>Kondo</surname><given-names>N.</given-names></name>
<name><surname>Nakatsue</surname><given-names>T.</given-names></name>
<name><surname>Abe</surname><given-names>A.</given-names></name>
<name><surname>Ito</surname><given-names>S.</given-names></name>
</person-group><article-title>Serum hepcidin level, iron metabolism and osteoporosis in patients with rheumatoid arthritis</article-title><source>Sci. Rep.</source><year>2020</year><volume>10</volume><elocation-id>9882</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-020-66945-3</pub-id><pub-id pub-id-type="pmid">32555299</pub-id>
</element-citation></ref><ref id="B36-vetsci-12-00122"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ta&#x00144;ski</surname><given-names>W.</given-names></name>
<name><surname>Chabowski</surname><given-names>M.</given-names></name>
<name><surname>Jankowska-Pola&#x00144;ska</surname><given-names>B.</given-names></name>
<name><surname>Jankowska</surname><given-names>E.A.</given-names></name>
</person-group><article-title>Iron metabolism in patients with rheumatoid arthritis</article-title><source>Res. Sq.</source><year>2020</year><volume>25</volume><fpage>4325</fpage><lpage>4335</lpage><pub-id pub-id-type="doi">10.21203/rs.3.rs-29281/v1</pub-id></element-citation></ref><ref id="B37-vetsci-12-00122"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Masella</surname><given-names>R.</given-names></name>
<name><surname>Di Benedetto</surname><given-names>R.</given-names></name>
<name><surname>Var&#x000ec;</surname><given-names>R.</given-names></name>
<name><surname>Filesi</surname><given-names>C.</given-names></name>
<name><surname>Giovannini</surname><given-names>C.</given-names></name>
</person-group><article-title>Novel mechanisms of natural antioxidant compounds in biological systems: Involvement of glutathione and glutathione-related enzymes</article-title><source>J. Nutr. Biochem.</source><year>2005</year><volume>16</volume><fpage>577</fpage><lpage>586</lpage><pub-id pub-id-type="doi">10.1016/j.jnutbio.2005.05.013</pub-id><pub-id pub-id-type="pmid">16111877</pub-id>
</element-citation></ref><ref id="B38-vetsci-12-00122"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Glasauer</surname><given-names>A.</given-names></name>
<name><surname>Chandel</surname><given-names>N.S.</given-names></name>
</person-group><article-title>Targeting antioxidants for cancer therapy</article-title><source>Biochem. Pharmacol.</source><year>2014</year><volume>92</volume><fpage>90</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1016/j.bcp.2014.07.017</pub-id><pub-id pub-id-type="pmid">25078786</pub-id>
</element-citation></ref><ref id="B39-vetsci-12-00122"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bourens</surname><given-names>M.</given-names></name>
<name><surname>Barrientos</surname><given-names>A.</given-names></name>
</person-group><article-title>Human mitochondrial cytochrome c oxidase assembly factor COX18 acts transiently as a membrane insertase within the subunit 2 maturation module</article-title><source>J. Biol. Chem.</source><year>2017</year><volume>292</volume><fpage>7774</fpage><lpage>7783</lpage><pub-id pub-id-type="doi">10.1074/jbc.M117.778514</pub-id><pub-id pub-id-type="pmid">28330871</pub-id>
</element-citation></ref><ref id="B40-vetsci-12-00122"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Al-Sharif</surname><given-names>M.</given-names></name>
<name><surname>Ateya</surname><given-names>A.</given-names></name>
</person-group><article-title>New insights on coding mutations and mRNA levels of candidate genes associated with diarrhea susceptibility in baladi goat</article-title><source>Agriculture</source><year>2023</year><volume>13</volume><elocation-id>143</elocation-id><pub-id pub-id-type="doi">10.3390/agriculture13010143</pub-id></element-citation></ref><ref id="B41-vetsci-12-00122"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Krishna Priya</surname><given-names>E.</given-names></name>
<name><surname>Srinivas</surname><given-names>L.</given-names></name>
<name><surname>Rajesh</surname><given-names>S.</given-names></name>
<name><surname>Sasikala</surname><given-names>K.</given-names></name>
<name><surname>Banerjee</surname><given-names>M.</given-names></name>
</person-group><article-title>Pro-inflammatory cytokine response pre-dominates immuno-genetic pathway in development of rheumatoid arthritis</article-title><source>Mol. Biol. Rep.</source><year>2020</year><volume>47</volume><fpage>8669</fpage><lpage>8677</lpage><pub-id pub-id-type="doi">10.1007/s11033-020-05909-2</pub-id><pub-id pub-id-type="pmid">33074413</pub-id>
</element-citation></ref><ref id="B42-vetsci-12-00122"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hernandez</surname><given-names>G.</given-names></name>
<name><surname>Mills</surname><given-names>T.S.</given-names></name>
<name><surname>Rabe</surname><given-names>J.L.</given-names></name>
<name><surname>Chavez</surname><given-names>J.S.</given-names></name>
<name><surname>Kuldanek</surname><given-names>S.</given-names></name>
<name><surname>Kirkpatrick</surname><given-names>G.</given-names></name>
<name><surname>Noetzli</surname><given-names>L.</given-names></name>
<name><surname>Jubair</surname><given-names>W.K.</given-names></name>
<name><surname>Zanche</surname><given-names>M.</given-names></name>
<name><surname>Myers</surname><given-names>J.R.</given-names></name>
</person-group><article-title>Pro-inflammatory cytokine blockade attenuates myeloid expansion in a murine model of rheumatoid arthritis</article-title><source>Haematologica</source><year>2020</year><volume>105</volume><fpage>585</fpage><pub-id pub-id-type="doi">10.3324/haematol.2018.197210</pub-id><pub-id pub-id-type="pmid">31101752</pub-id>
</element-citation></ref><ref id="B43-vetsci-12-00122"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tothova</surname><given-names>C.</given-names></name>
<name><surname>Nagy</surname><given-names>O.</given-names></name>
<name><surname>Kovac</surname><given-names>G.</given-names></name>
</person-group><article-title>Acute phase proteins and their use in the diagnosis of diseases in ruminants: A review</article-title><source>Veterin&#x000e1;rn&#x000ed; Medic&#x000ed;na</source><year>2014</year><volume>59</volume><fpage>163</fpage><lpage>180</lpage><pub-id pub-id-type="doi">10.17221/7478-VETMED</pub-id></element-citation></ref><ref id="B44-vetsci-12-00122"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Iliev</surname><given-names>P.</given-names></name>
<name><surname>Georgieva</surname><given-names>T.</given-names></name>
</person-group><article-title>Acute phase proteins in sheep and goats-function, reference ranges and assessment methods: An overview</article-title><source>Bulg. J. Vet. Med.</source><year>2018</year><volume>21</volume><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.15547/bjvm.1050</pub-id></element-citation></ref><ref id="B45-vetsci-12-00122"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Reczy&#x00144;ska</surname><given-names>D.</given-names></name>
<name><surname>Zalewska</surname><given-names>M.</given-names></name>
<name><surname>Czopowicz</surname><given-names>M.</given-names></name>
<name><surname>Kaba</surname><given-names>J.</given-names></name>
<name><surname>Zwierzchowski</surname><given-names>L.</given-names></name>
<name><surname>Bagnicka</surname><given-names>E.</given-names></name>
</person-group><article-title>Acute phase protein levels as an auxiliary tool in diagnosing viral diseases in ruminants&#x02014;A review</article-title><source>Viruses</source><year>2018</year><volume>10</volume><elocation-id>502</elocation-id><pub-id pub-id-type="doi">10.3390/v10090502</pub-id><pub-id pub-id-type="pmid">30223561</pub-id>
</element-citation></ref><ref id="B46-vetsci-12-00122"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kay</surname><given-names>J.</given-names></name>
<name><surname>Morgacheva</surname><given-names>O.</given-names></name>
<name><surname>Messing</surname><given-names>S.P.</given-names></name>
<name><surname>Kremer</surname><given-names>J.M.</given-names></name>
<name><surname>Greenberg</surname><given-names>J.D.</given-names></name>
<name><surname>Reed</surname><given-names>G.W.</given-names></name>
<name><surname>Gravallese</surname><given-names>E.M.</given-names></name>
<name><surname>Furst</surname><given-names>D.E.</given-names></name>
</person-group><article-title>Clinical disease activity and acute phase reactant levels are discordant among patients with active rheumatoid arthritis: Acute phase reactant levels contribute separately to predicting outcome at one year</article-title><source>Arthritis Res. Ther.</source><year>2014</year><volume>16</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1186/ar4469</pub-id></element-citation></ref><ref id="B47-vetsci-12-00122"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Darwish</surname><given-names>A.</given-names></name>
</person-group><article-title>Monitoring of antioxidant vitamins concentrations in some ovine diseases</article-title><source>Vet. Sci. Res. Rev.</source><year>2020</year><volume>6</volume><fpage>58</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.17582/journal.vsrr/2020/6.2.58.63</pub-id></element-citation></ref><ref id="B48-vetsci-12-00122"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ponnampalam</surname><given-names>E.N.</given-names></name>
<name><surname>Kiani</surname><given-names>A.</given-names></name>
<name><surname>Santhiravel</surname><given-names>S.</given-names></name>
<name><surname>Holman</surname><given-names>B.W.</given-names></name>
<name><surname>Lauridsen</surname><given-names>C.</given-names></name>
<name><surname>Dunshea</surname><given-names>F.R.</given-names></name>
</person-group><article-title>The importance of dietary antioxidants on oxidative stress, meat and milk production, and their preservative aspects in farm animals: Antioxidant action, animal health, and product quality&#x02014;Invited review</article-title><source>Animals</source><year>2022</year><volume>12</volume><elocation-id>3279</elocation-id><pub-id pub-id-type="doi">10.3390/ani12233279</pub-id><pub-id pub-id-type="pmid">36496798</pub-id>
</element-citation></ref><ref id="B49-vetsci-12-00122"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Triggianese</surname><given-names>P.</given-names></name>
<name><surname>Conigliaro</surname><given-names>P.</given-names></name>
<name><surname>De Martino</surname><given-names>E.</given-names></name>
<name><surname>Monosi</surname><given-names>B.</given-names></name>
<name><surname>Chimenti</surname><given-names>M.S.</given-names></name>
</person-group><article-title>Overview on the Link Between the Complement System and Auto-Immune Articular and Pulmonary Disease</article-title><source>Open Access Rheumatol. Res. Rev.</source><year>2023</year><volume>15</volume><fpage>65</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.2147/OARRR.S318826</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="vetsci-12-00122-f001"><label>Figure 1</label><caption><p>Rams with arthritis and normal rams had different immune gene transcript levels. A significance level of <italic toggle="yes">p</italic> &#x0003c; 0.05 is indicated by the symbol *.</p></caption><graphic xlink:href="vetsci-12-00122-g001" position="float"/></fig><fig position="float" id="vetsci-12-00122-f002"><label>Figure 2</label><caption><p>Rams with arthritis and normal rams had different antioxidant gene transcript levels. A significance level of <italic toggle="yes">p</italic> &#x0003c; 0.05 is indicated by the symbol *.</p></caption><graphic xlink:href="vetsci-12-00122-g002" position="float"/></fig><table-wrap position="float" id="vetsci-12-00122-t001"><object-id pub-id-type="pii">vetsci-12-00122-t001_Table 1</object-id><label>Table 1</label><caption><p>Forward and reverse oligonucleotide-based real-time PCR primers for the immunological and antioxidant genes being investigated.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Investigated Marker</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Primer</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Product Size (bp)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Annealing <break/>Temperature (&#x000b0;C)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">GenBank Isolate</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Origin</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">IL-1&#x003b1;</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">F5&#x02032;-AGAAGTCCTTCTATGATGCAAG-3&#x02032;<break/>R5&#x02032;-GAGATTCTTAGAGTCACAGGA-3&#x02032;</td><td align="center" valign="middle" rowspan="1" colspan="1">466</td><td align="center" valign="middle" rowspan="1" colspan="1">60</td><td align="center" valign="middle" rowspan="1" colspan="1">NM_001009808.1 </td><td rowspan="16" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Present <break/>Research</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">IL-1&#x003b2;</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">F5&#x02032;-CAGCCATGGCAACCGTACCTG-3&#x02032;<break/>R5&#x02032;-ACTGACTGCACGGCTGCATCAC-3&#x02032;</td><td align="center" valign="middle" rowspan="1" colspan="1">361</td><td align="center" valign="middle" rowspan="1" colspan="1">60</td><td align="center" valign="middle" rowspan="1" colspan="1">NM_001009465.2</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">IL-6</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">F5&#x02032;-GTAGTTCCTGGGCATTCCCTC-3&#x02032;<break/>R5&#x02032;-CAGCCTAAACATATAAATACA-3&#x02032;</td><td align="center" valign="middle" rowspan="1" colspan="1">370</td><td align="center" valign="middle" rowspan="1" colspan="1">58</td><td align="center" valign="middle" rowspan="1" colspan="1">NM_001009392.1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">TNF&#x003b1;</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">F5&#x02032;-CCTGCCGGAATACCTGGACTAT-3&#x02032;<break/>R5&#x02032;-CTCAAGGAACGTTGCGAAGTAT-3&#x02032;</td><td align="center" valign="middle" rowspan="1" colspan="1">386</td><td align="center" valign="middle" rowspan="1" colspan="1">60</td><td align="center" valign="middle" rowspan="1" colspan="1">NM_001024860.1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">IL10</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">F5&#x02032;-CTGAAGACCCTCCGGCTGCGGC-3&#x02032;<break/>R5&#x02032;-TCACAGAGAAGCTCAGTAAATA-3&#x02032;</td><td align="center" valign="middle" rowspan="1" colspan="1">387</td><td align="center" valign="middle" rowspan="1" colspan="1">58</td><td align="center" valign="middle" rowspan="1" colspan="1">NM_001009327.1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">NFKB</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">F5&#x02032;-ATCCACCTGCACGCACACAGC-3&#x02032;<break/>R5&#x02032;-GCTGTCATAGATGGCGTCCGAC-3&#x02032;</td><td align="center" valign="middle" rowspan="1" colspan="1">411</td><td align="center" valign="middle" rowspan="1" colspan="1">60</td><td align="center" valign="middle" rowspan="1" colspan="1">XM_060416845.1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">NCF4</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">F5&#x02032;-AGAGGCAGCTCCTGGGGACTC-3&#x02032;<break/>R5&#x02032;-GAAGCGCTCCTCCAGCTTGCT-3&#x02032;</td><td align="center" valign="middle" rowspan="1" colspan="1">345</td><td align="center" valign="middle" rowspan="1" colspan="1">60</td><td align="center" valign="middle" rowspan="1" colspan="1">XM_042247241.2</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">TMED1</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">F5&#x02032;-AGCACTGGCTGGCTTGCAGGT-3&#x02032;<break/>R5&#x02032;-GTGACTGTTCTGGCAAGAACAC-3&#x02032;</td><td align="center" valign="middle" rowspan="1" colspan="1">408</td><td align="center" valign="middle" rowspan="1" colspan="1">58</td><td align="center" valign="middle" rowspan="1" colspan="1">XM_060415483.1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">FCAMR</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">F5&#x02032;-GAGGCTTGTTCGTGGTGAGGCT-3&#x02032;<break/>R5&#x02032;-CGGAGCCCTCTGCCTGGCTGC-3&#x02032;</td><td align="center" valign="middle" rowspan="1" colspan="1">378</td><td align="center" valign="middle" rowspan="1" colspan="1">58</td><td align="center" valign="middle" rowspan="1" colspan="1">XM_042257020.1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">iNOS</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">F5&#x02032;-CAGGAACCTACCAGCTGACGG-3&#x02032;<break/>R5&#x02032;-GGTCGCGGCCGTCAGCCTGCA-3&#x02032;</td><td align="center" valign="middle" rowspan="1" colspan="1">480</td><td align="center" valign="middle" rowspan="1" colspan="1">60</td><td align="center" valign="middle" rowspan="1" colspan="1">AF223942.1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">SOD</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">F5&#x02032;-ATCCGCGACATGCACGCCAAG-3&#x02032;<break/>R5&#x02032;-CCAGACCTGGCCATCTCGCAC-3&#x02032;</td><td align="center" valign="middle" rowspan="1" colspan="1">381</td><td align="center" valign="middle" rowspan="1" colspan="1">60</td><td align="center" valign="middle" rowspan="1" colspan="1">XM_027970902.2</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">CAT</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">F5&#x02032;-CTGATGTCCTGACCACTGGCGC-3&#x02032;<break/>R5&#x02032;-CATGTCCGGATCCTTCAGGTG-3&#x02032;</td><td align="center" valign="middle" rowspan="1" colspan="1">473</td><td align="center" valign="middle" rowspan="1" colspan="1">58</td><td align="center" valign="middle" rowspan="1" colspan="1">XM_060400055.1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">GPX</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">F5&#x02032;-AGCTCACTGCTCTCAACTTGG-3&#x02032;<break/>R5&#x02032;-AGAGCGGATGCGCCTTCTCGC-3&#x02032;</td><td align="center" valign="middle" rowspan="1" colspan="1">416</td><td align="center" valign="middle" rowspan="1" colspan="1">58</td><td align="center" valign="middle" rowspan="1" colspan="1">XM_004018462.5</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">ATOX1</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">F5&#x02032;-CGTTGCTGTCGGAGGCGTAGTC-3&#x02032;<break/>R5&#x02032;-CGGCTTGACTTTATTGCAGGGA-3&#x02032;</td><td align="center" valign="middle" rowspan="1" colspan="1">430</td><td align="center" valign="middle" rowspan="1" colspan="1">58</td><td align="center" valign="middle" rowspan="1" colspan="1">NM_001009429.1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">COX18</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">F5&#x02032;-ATGCGCGTAGAGGCCTCGGCG 3&#x02032;<break/>R5&#x02032;-GATGTAGTGCTGGTAGGCAGC-3&#x02032;</td><td align="center" valign="middle" rowspan="1" colspan="1">415</td><td align="center" valign="middle" rowspan="1" colspan="1">60</td><td align="center" valign="middle" rowspan="1" colspan="1">XM_027971062.3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">&#x000df;. actin</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">F5&#x02032;-AATTCCATCATGAAGTGTGAC-3&#x02032;<break/>R5&#x02032;-GATCTTGATCTTCATCGTGCT-3&#x02032;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">150</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">58</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">KU365062.1</td></tr></tbody></table></table-wrap><table-wrap position="float" id="vetsci-12-00122-t002"><object-id pub-id-type="pii">vetsci-12-00122-t002_Table 2</object-id><label>Table 2</label><caption><p>Immunological and antioxidant marker distribution in healthy and arthritic rams with a single base difference and possible genetic change.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Gene</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">SNPs</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Healthy<break/><italic toggle="yes">n</italic> = 30</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Arthritic<break/><italic toggle="yes">n</italic> = 30</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Total<break/><italic toggle="yes">n</italic> = 60</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Kind of Inherited Change</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Amino Acid Order and Sorting</th></tr></thead><tbody><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic toggle="yes">IL-1&#x003b1;</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C185T</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">31/60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Non-synonymous</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">62 P to L</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">T191C</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21/60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Non-synonymous</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">64 M to T</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A363C</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13/60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Synonymous</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">121 T</td></tr><tr><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic toggle="yes">IL-1&#x003b2;</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C29T</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19/60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Non-synonymous</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10 S to L</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C46A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23/60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Non-synonymous</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16 A to T</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A58C</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11/60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Synonymous</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20 R</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">T89C</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14/60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Non-synonymous</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30 L to P</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">IL-6</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C341T</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17/60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Non-synonymous</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">114 T to I</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">TNF&#x003b1;</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C242T</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24/60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Non-synonymous</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">81 T to M</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic toggle="yes">IL10</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">T39C</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14/60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Synonymous</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13 R</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">G219C</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19/60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Non-synonymous</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">73 R to S</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic toggle="yes">NFKB</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C66T</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13/60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Synonymous</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22 A</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A264G</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22/60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Synonymous</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">88 K</td></tr><tr><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic toggle="yes">NCF4</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">G36T</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15/60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Synonymous</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12 P</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">G38A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17/60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Non-synonymous</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13 R to K</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C243T</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19/60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Synonymous</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">81 F</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">G261A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24/60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Synonymous</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">87 V</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A267G</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15/60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Synonymous</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">89 T</td></tr><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic toggle="yes">TMED1</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">G125C</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12/60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Non-synonymous</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">42 G to A</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">G147A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14/60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Synonymous</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">49 V</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">T337C</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22/60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Non-synonymous</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">113 W to L</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">FCAMR</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C268T</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14/60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Synonymous</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">90 L</td></tr><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic toggle="yes">iNOS</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C38T</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19/60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Non-synonymous</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13 S to L</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C77T</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18/60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Non-synonymous</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">26 S to L</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">T410C</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15/60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Non-synonymous</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">137 M to T</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">SOD</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C147G</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22/60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Non-synonymous</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">49 S to R</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">CAT</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C155T</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19/60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Non-synonymous</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">52 T to M</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic toggle="yes">GPX</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C193A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10/60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Non-synonymous</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">65 H to N</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C298T</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23/60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Non-synonymous</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100 R to C</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">ATOX1</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">G383C</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17/60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Non-synonymous</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">128 R to P</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">COX18</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">T110C</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-/30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21/60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Non-synonymous</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">37 V to A</td></tr></tbody></table><table-wrap-foot><fn><p>Fisher&#x02019;s exact analysis revealed that the immune and antioxidant markers&#x02019; single base difference distribution varied significantly (<italic toggle="yes">p</italic> &#x0003c; 0.01) between rams with and without arthritis. A = Alanine; C = Cysteine; F = Phenylalanine; G = Glycine; H = Histidine; I = Isoleucine; K = Lysine; L = Leucine; M = Methionine; N = Asparagine; P = Proline; R = Arginine; S = Serine; T = Threonine; V = Valine; and W = Tryptophan.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="vetsci-12-00122-t003"><object-id pub-id-type="pii">vetsci-12-00122-t003_Table 3</object-id><label>Table 3</label><caption><p>Immunological, APP, antioxidant, hormonal assay and iron profiles of arthritic group (AG) compared to control (CG); values are means &#x000b1; SD.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Parameters</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">CG</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">AG</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IL-1&#x003b1; (Pg/mL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24.05 &#x000b1; 3.34</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">95.73 &#x000b1; 1.78 *</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IL-1&#x003b2; (Pg/mL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25.99 &#x000b1; 2.96</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">99.14 &#x000b1; 0.64 *</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IL-6 (Pg/mL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24.63 &#x000b1; 2.92</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">86.38 &#x000b1; 0.08 *</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TNF-&#x003b1; (Pg/mL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24.91 &#x000b1; 2.98</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">87.24 &#x000b1; 1.70 *</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IL-10 (Pg/mL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">103.70 &#x000b1; 3.31</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">90.69 &#x000b1; 2.26 *</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IgG (mg/dL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">229.02 &#x000b1; 19.74</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">350.26 &#x000b1; 36.38 *</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IgM (mg/dL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13.79 &#x000b1; 1.43</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">41.43 &#x000b1; 5.95 *</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IgA (mg/dL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.49 &#x000b1; 0.83</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.62 &#x000b1; 0.66 *</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C3 (mg/dL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">151.17 &#x000b1; 5.29</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">110.68 &#x000b1; 1.74 *</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C4 (mg/dL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12.07 &#x000b1; 0.60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.14 &#x000b1; 0.83 *</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fb (mg/dL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">122.01 &#x000b1; 8.49</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">225.01 &#x000b1; 3.70 *</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cp (mg/dL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.30 &#x000b1; 1.15</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.24 &#x000b1; 0.03 *</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hp (g/dL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.15 &#x000b1; 0.02</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.59 &#x000b1; 0.49 *</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SAA (mg/L)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.32 &#x000b1; 0.15</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.94 &#x000b1; 0.16 *</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MDA (nmol/mL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12.95 &#x000b1; 1.14</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23.70 &#x000b1; 1.52 *</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NO (&#x003bc;mol/L)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">26.80 &#x000b1; 1.20</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">32.91 &#x000b1; 1.78 *</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GSH (ng/mL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.15 &#x000b1; 0.62</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.06 &#x000b1; 0.51 *</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CAT (U/L)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">412.25 &#x000b1; 14.64</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">289.20 &#x000b1; 6.16 *</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GPx (mU/L)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1015.45 &#x000b1; 2.95</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">745.01 &#x000b1; 15.65 *</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cortisol (&#x003bc;g/dL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.79 &#x000b1; 0.16</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.44 &#x000b1; 0.06 *</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Insulin (&#x003bc;IU/mL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.41 &#x000b1; 0.15</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.09 &#x000b1; 0.17 *</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">T3(ng/mL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.74 &#x000b1; 0.15</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.02 &#x000b1; 0.01 *</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">T4 (&#x000b5;g/mL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.85 &#x000b1; 0.08</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.64 &#x000b1; 0.02 *</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TSH (&#x000b5;IU/mL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.010 &#x000b1; 0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.022 &#x000b1; 0.012 *</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GH (ng/dL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12.39 &#x000b1; 1.47</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16.80 &#x000b1; 0.06 *</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SI (&#x003bc;g/dL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">106.89 &#x000b1; 2.46</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">89.36 &#x000b1; 1.57 *</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TIBC (&#x003bc;g/dL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">327.39 &#x000b1; 2.16</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">341.06 &#x000b1; 3.20 *</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">UIBC (&#x003bc;g/dL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">220.50 &#x000b1; 2.24</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">251.69 &#x000b1; 2.74 *</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Transferrin(mg/dL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">124.65 &#x000b1; 2.74</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">86.54 &#x000b1; 0.24 *</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tf sat.%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">32.65 &#x000b1; 0.66</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">26.20 &#x000b1; 0.39 *</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ferritin (ng/mL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13.60 &#x000b1; 1.05</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19.54 &#x000b1; 0.53 *</td></tr></tbody></table><table-wrap-foot><fn><p>IL1-&#x003b1; Interleukin 1 alpha; IL1-&#x003b2; Interleukin 1 beta; IL6 Interleukin 6; TNF-&#x003b1; Tumor necrosis factor-alpha; IL10 Interleukin 10; Fb Fibrinogen; Cp Caeruloplasmin; Hp Haptoglobin; SAA Serum amyloid A; MDA Malondialdhyde; NO Nitric oxide; GSH Glutathione reductase; CAT Catalase; GPx Glutathione peroxidase. Statistical significance between AG and CG is indicated by (*), when <italic toggle="yes">p</italic> &#x0003c; 0.05. IgG Immunoglobulin G; IgM Immunoglobulin M; IgA Immunoglobulin A; C3 Complement-3; C4 Complement-4; T3 Triiodothyronine; T4 Thyroxine; TSH Thyroid stimulating hormone; GH Growth hormone; SI Serum iron; TIBC Total iron capacity; UIBC Unsaturated iron binding capacity; Tf Transferrin.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="vetsci-12-00122-t004"><object-id pub-id-type="pii">vetsci-12-00122-t004_Table 4</object-id><label>Table 4</label><caption><p>Cut-off points, sensitivity, specificity, LR, PPV, NPV, accuracy rate and percentages of increase or decrease in interleukins and APPs in AG compared to CG.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Parameter</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">IL-1&#x003b1; (Pg/mL)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">IL-1&#x003b2; (Pg/mL)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">IL-6 (Pg/mL)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">TNF-&#x003b1; (Pg/mL)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">IL-10 (Pg/mL)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Fb (mg/dL)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">SAA (mg/L)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Hp (g/dL)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cp (mg/dL)</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cut-off</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">29.50</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">28.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">28.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">28.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100.80</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">132.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.45</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.185</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.60</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sensitivity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100%</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Specificity </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">90%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">85%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">90%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">90%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">80%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">85%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">80%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">90%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">80%</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LR</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.67</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.67</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PPV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">90.91%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">86.96%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">90.91%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">90.91%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">83.33%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">86.96%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">83.33%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">90.91%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">83.33%</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NPV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100%</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Accuracy rate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">95%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">92.5%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">95%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">95%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">90%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">92.5%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">90%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">95%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">90%</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">% increase or decrease </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">298.05%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">281.45%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">226.35%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">250.22%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;12.57%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">84.41%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">199.14%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1626.67%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">171.30%</td></tr></tbody></table><table-wrap-foot><fn><p>IL1-&#x003b1; Interleukin 1 alpha; IL1-&#x003b2; Interleukin 1 beta; IL6 Interleukin 6; TNF-&#x003b1; Tumor necrosis factor-alpha; IL10 Interleukin 10; Fb Fibrino gen; SAA Serum amyloid A; Hp Haptoglobin; Cp Caeruloplasmin; LR: Likelihood ratio, PPV: Positive predictive value, NPV: Negative predictive value. LR = 0.5&#x02013;5: low; LR = 5&#x02013;10: moderate; LR &#x0003e; 10: high.</p></fn></table-wrap-foot></table-wrap></floats-group></article>